| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF21B MYO1E COQ8B RFC2 MORC2 ABCA8 BLM ATP11B SMC3 CHD5 SMARCA4 MACF1 ABCC12 KIF3C HSP90AB2P DNAH8 TAP2 HSP90AA1 HSP90AA4P HSP90AA2P HSP90AB1 | 1.95e-11 | 441 | 151 | 21 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF21B DNHD1 MYO1E COQ8B RFC2 MORC2 ABCA8 BLM ATP11B SMC3 CHD5 SMARCA2 SMARCA4 MACF1 ABCC12 KIF3C HSP90AB2P DNAH8 TAP2 HSP90AA1 HSP90AA4P HSP90AA2P HSP90AB1 | 2.41e-10 | 614 | 151 | 23 | GO:0140657 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KIF21B MYO1E COQ8B RFC2 MORC2 ABCA8 BLM ATP11B SMC3 CHD5 SMARCA4 MACF1 ABCC12 KIF3C HSP90AB2P DNAH8 TAP2 HSP90AA1 HSP90AA4P HSP90AA2P HSP90AB1 | 4.00e-07 | 775 | 151 | 21 | GO:0017111 |
| GeneOntologyMolecularFunction | disordered domain specific binding | 4.49e-07 | 39 | 151 | 6 | GO:0097718 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | KIF21B MYO1E COQ8B RFC2 MORC2 ABCA8 BLM ATP11B SMC3 CHD5 SMARCA4 MACF1 ABCC12 KIF3C HSP90AB2P DNAH8 TAP2 HSP90AA1 HSP90AA4P HSP90AA2P HSP90AB1 | 1.44e-06 | 839 | 151 | 21 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | KIF21B MYO1E COQ8B RFC2 MORC2 ABCA8 BLM ATP11B SMC3 CHD5 SMARCA4 MACF1 ABCC12 KIF3C HSP90AB2P DNAH8 TAP2 HSP90AA1 HSP90AA4P HSP90AA2P HSP90AB1 | 1.46e-06 | 840 | 151 | 21 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | KIF21B MYO1E COQ8B RFC2 MORC2 ABCA8 BLM ATP11B SMC3 CHD5 SMARCA4 MACF1 ABCC12 KIF3C HSP90AB2P DNAH8 TAP2 HSP90AA1 HSP90AA4P HSP90AA2P HSP90AB1 | 1.46e-06 | 840 | 151 | 21 | GO:0016818 |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 4.19e-06 | 5 | 151 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 1.23e-05 | 40 | 151 | 5 | GO:0140662 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase regulator activity | 4.89e-05 | 10 | 151 | 3 | GO:0030235 | |
| GeneOntologyMolecularFunction | CTP binding | 5.68e-05 | 2 | 151 | 2 | GO:0002135 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIF21B DLG5 BIN1 MYLK MYO1E SYNM SYNE1 SPTBN1 CAPN3 APC MAPK8IP3 ABLIM1 LRPPRC BRCA2 SMC3 CTNNA3 PXN MACF1 KIF3C HSP90AA1 HSP90AB1 | 8.31e-05 | 1099 | 151 | 21 | GO:0008092 |
| GeneOntologyMolecularFunction | sodium ion binding | 1.45e-04 | 14 | 151 | 3 | GO:0031402 | |
| GeneOntologyMolecularFunction | sulfonylurea receptor binding | 1.70e-04 | 3 | 151 | 2 | GO:0017098 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.89e-04 | 70 | 151 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | protein folding chaperone | 2.30e-04 | 73 | 151 | 5 | GO:0044183 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.78e-04 | 118 | 151 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | UTP binding | 3.37e-04 | 4 | 151 | 2 | GO:0002134 | |
| GeneOntologyMolecularFunction | receptor ligand inhibitor activity | 3.37e-04 | 4 | 151 | 2 | GO:0141069 | |
| GeneOntologyMolecularFunction | actin filament binding | 3.40e-04 | 227 | 151 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | pyrimidine ribonucleotide binding | 5.60e-04 | 5 | 151 | 2 | GO:0032557 | |
| GeneOntologyMolecularFunction | dATP binding | 5.60e-04 | 5 | 151 | 2 | GO:0032564 | |
| GeneOntologyMolecularFunction | DNA polymerase binding | 6.72e-04 | 23 | 151 | 3 | GO:0070182 | |
| GeneOntologyMolecularFunction | adenyl deoxyribonucleotide binding | 8.35e-04 | 6 | 151 | 2 | GO:0032558 | |
| GeneOntologyMolecularFunction | histone binding | 9.40e-04 | 265 | 151 | 8 | GO:0042393 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 9.70e-04 | 26 | 151 | 3 | GO:0031420 | |
| GeneOntologyMolecularFunction | purine deoxyribonucleotide binding | 1.16e-03 | 7 | 151 | 2 | GO:0032554 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | SOX6 SYNE1 SCLY MORC2 HIF1AN STAT1 GSTA3 BLM ACOD1 TENM4 RPEL1 COQ9 TAP2 HSP90AA1 HSP90AB1 | 1.33e-03 | 815 | 151 | 15 | GO:0042803 |
| GeneOntologyMolecularFunction | histone acetyltransferase binding | 1.34e-03 | 29 | 151 | 3 | GO:0035035 | |
| GeneOntologyMolecularFunction | TPR domain binding | 1.54e-03 | 8 | 151 | 2 | GO:0030911 | |
| GeneOntologyMolecularFunction | calcium-independent phospholipase A2 activity | 1.98e-03 | 9 | 151 | 2 | GO:0047499 | |
| GeneOntologyMolecularFunction | deoxyribonucleotide binding | 1.98e-03 | 9 | 151 | 2 | GO:0032552 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 2.20e-03 | 120 | 151 | 5 | GO:0008013 | |
| GeneOntologyMolecularFunction | protease binding | 2.57e-03 | 181 | 151 | 6 | GO:0002020 | |
| GeneOntologyMolecularFunction | unfolded protein binding | 2.71e-03 | 126 | 151 | 5 | GO:0051082 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 2.73e-03 | 37 | 151 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.81e-03 | 127 | 151 | 5 | GO:0008094 | |
| GeneOntologyMolecularFunction | phosphatidyl phospholipase B activity | 2.99e-03 | 11 | 151 | 2 | GO:0102545 | |
| GeneOntologyMolecularFunction | pyrimidine nucleotide binding | 2.99e-03 | 11 | 151 | 2 | GO:0019103 | |
| GeneOntologyMolecularFunction | signaling adaptor activity | 3.00e-03 | 129 | 151 | 5 | GO:0035591 | |
| GeneOntologyMolecularFunction | lipid binding | SESTD1 BIN1 MYO1E SPTBN1 COQ8B PARD3B STAR GSTA3 RASA4 COQ9 SCP2 PLA2G4A RASA4B C3 SERPINA5 PSD4 | 3.35e-03 | 988 | 151 | 16 | GO:0008289 |
| GeneOntologyBiologicalProcess | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 1.50e-06 | 4 | 150 | 3 | GO:0003340 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell differentiation involved in kidney development | 7.42e-06 | 6 | 150 | 3 | GO:2000697 | |
| GeneOntologyBiologicalProcess | ubiquinone metabolic process | 1.19e-05 | 20 | 150 | 4 | GO:0006743 | |
| GeneOntologyBiologicalProcess | central nervous system development | SOX6 KIF21B DLG5 BIN1 FZD3 SPTBN1 COQ8B DCC CCDC141 MAPK8IP3 WDR47 CITED2 TBX19 TENM4 SALL1 BRCA2 CHD5 SCN2A SMARCA4 C3 PRKDC CTNNB1 EN1 | 1.82e-05 | 1197 | 150 | 23 | GO:0007417 |
| GeneOntologyBiologicalProcess | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 3.07e-05 | 9 | 150 | 3 | GO:0003339 | |
| GeneOntologyBiologicalProcess | telomere maintenance | 3.23e-05 | 168 | 150 | 8 | GO:0000723 | |
| GeneOntologyBiologicalProcess | quinone metabolic process | 3.55e-05 | 26 | 150 | 4 | GO:1901661 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic cell cycle, embryonic | 5.25e-05 | 2 | 150 | 2 | GO:0045976 | |
| GeneOntologyBiologicalProcess | mesenchymal to epithelial transition involved in metanephros morphogenesis | 7.90e-05 | 12 | 150 | 3 | GO:0003337 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | SOX6 BIN1 FZD3 COMMD5 APC HIF1AN STAR STAT1 MAPK8IP3 CDKL5 TENM4 SALL1 SMARCA2 SMARCA4 MACF1 ZFHX3 ASXL2 PRKDC CTNNB1 HSP90AA1 HSP90AB1 | 8.12e-05 | 1141 | 150 | 21 | GO:0045597 |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 8.60e-05 | 99 | 150 | 6 | GO:0045104 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 8.82e-05 | 62 | 150 | 5 | GO:0086002 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 9.09e-05 | 100 | 150 | 6 | GO:0045103 | |
| GeneOntologyBiologicalProcess | telomere organization | 1.07e-04 | 199 | 150 | 8 | GO:0032200 | |
| GeneOntologyBiologicalProcess | head development | SOX6 KIF21B DLG5 FZD3 COQ8B CCDC141 MAPK8IP3 WDR47 TBX19 SALL1 BRCA2 WDR11 CHD5 SCN2A SMARCA4 PRKDC CTNNB1 EN1 | 1.27e-04 | 919 | 150 | 18 | GO:0060322 |
| GeneOntologyBiologicalProcess | glial cell fate determination | 1.57e-04 | 3 | 150 | 2 | GO:0007403 | |
| GeneOntologyBiologicalProcess | metanephric renal vesicle morphogenesis | 1.61e-04 | 15 | 150 | 3 | GO:0072283 | |
| GeneOntologyBiologicalProcess | brain development | SOX6 KIF21B DLG5 FZD3 COQ8B CCDC141 MAPK8IP3 WDR47 TBX19 SALL1 BRCA2 CHD5 SCN2A SMARCA4 PRKDC CTNNB1 EN1 | 1.75e-04 | 859 | 150 | 17 | GO:0007420 |
| GeneOntologyBiologicalProcess | response to osmotic stress | 1.78e-04 | 113 | 150 | 6 | GO:0006970 | |
| GeneOntologyBiologicalProcess | cellular response to osmotic stress | 1.80e-04 | 72 | 150 | 5 | GO:0071470 | |
| GeneOntologyBiologicalProcess | vasculogenesis | 2.26e-04 | 118 | 150 | 6 | GO:0001570 | |
| GeneOntologyBiologicalProcess | ubiquinone biosynthetic process | 2.38e-04 | 17 | 150 | 3 | GO:0006744 | |
| GeneOntologyBiologicalProcess | quinone biosynthetic process | 2.38e-04 | 17 | 150 | 3 | GO:1901663 | |
| GeneOntologyBiologicalProcess | telomere maintenance via telomerase | 2.47e-04 | 77 | 150 | 5 | GO:0007004 | |
| GeneOntologyBiologicalProcess | cell fate specification | 2.83e-04 | 123 | 150 | 6 | GO:0001708 | |
| GeneOntologyBiologicalProcess | renal vesicle morphogenesis | 2.84e-04 | 18 | 150 | 3 | GO:0072077 | |
| GeneOntologyBiologicalProcess | cellular response to heat | 3.13e-04 | 81 | 150 | 5 | GO:0034605 | |
| GeneOntologyBiologicalProcess | renal vesicle development | 3.35e-04 | 19 | 150 | 3 | GO:0072087 | |
| GeneOntologyBiologicalProcess | glial cell fate commitment | 3.35e-04 | 19 | 150 | 3 | GO:0021781 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell differentiation involved in kidney development | 3.35e-04 | 19 | 150 | 3 | GO:2000696 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | MYLK FZD3 SYNE1 CAPN3 ZZEF1 LRRC8D DDB2 LETM1 STAT1 WDR47 BLM CITED2 BRCA2 SCN2A ANGPTL4 PRKDC HSP90AB2P CTNNB1 HSP90AA1 HSP90AA4P HSP90AA2P HSP90AB1 | 3.45e-04 | 1361 | 150 | 22 | GO:0009628 |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 3.50e-04 | 83 | 150 | 5 | GO:0006278 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 3.50e-04 | 237 | 150 | 8 | GO:0019827 | |
| GeneOntologyBiologicalProcess | nephron epithelium development | 3.50e-04 | 128 | 150 | 6 | GO:0072009 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation involved in kidney development | 3.76e-04 | 47 | 150 | 4 | GO:0035850 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | DLG5 MYLK KRT17 FZD3 COMMD5 APC STAT1 CITED2 TBX19 SALL1 SMARCA4 PXN MACF1 TBXT CTNNB1 | 3.83e-04 | 750 | 150 | 15 | GO:0048729 |
| GeneOntologyBiologicalProcess | mesenchymal to epithelial transition | 3.92e-04 | 20 | 150 | 3 | GO:0060231 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 4.02e-04 | 242 | 150 | 8 | GO:0098727 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 4.35e-04 | 87 | 150 | 5 | GO:0086001 | |
| GeneOntologyBiologicalProcess | nephron epithelium morphogenesis | 4.83e-04 | 89 | 150 | 5 | GO:0072088 | |
| GeneOntologyBiologicalProcess | myoblast differentiation | 4.84e-04 | 136 | 150 | 6 | GO:0045445 | |
| GeneOntologyBiologicalProcess | chromosome organization | APC RFC2 MORC2 BLM BRCA2 SMC3 XRN1 SMARCA2 SMARCA4 TNKS PRKDC CTNNB1 HSP90AA1 HSP90AB1 | 4.94e-04 | 686 | 150 | 14 | GO:0051276 |
| GeneOntologyBiologicalProcess | telomere maintenance via telomere lengthening | 5.09e-04 | 90 | 150 | 5 | GO:0010833 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle, embryonic | 5.18e-04 | 5 | 150 | 2 | GO:0009794 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle, embryonic | 5.18e-04 | 5 | 150 | 2 | GO:0045448 | |
| GeneOntologyBiologicalProcess | protein unfolding | 5.18e-04 | 5 | 150 | 2 | GO:0043335 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 5.25e-04 | 22 | 150 | 3 | GO:1902514 | |
| GeneOntologyBiologicalProcess | cell differentiation involved in metanephros development | 5.25e-04 | 22 | 150 | 3 | GO:0072202 | |
| GeneOntologyBiologicalProcess | nephron morphogenesis | 5.35e-04 | 91 | 150 | 5 | GO:0072028 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 5.63e-04 | 92 | 150 | 5 | GO:0048844 | |
| GeneOntologyBiologicalProcess | regulation of myoblast differentiation | 5.63e-04 | 92 | 150 | 5 | GO:0045661 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 5.91e-04 | 93 | 150 | 5 | GO:0086003 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport via high voltage-gated calcium channel | 6.00e-04 | 23 | 150 | 3 | GO:0061577 | |
| GeneOntologyBiologicalProcess | metanephric nephron morphogenesis | 6.00e-04 | 23 | 150 | 3 | GO:0072273 | |
| GeneOntologyBiologicalProcess | positive regulation of myoblast differentiation | 6.41e-04 | 54 | 150 | 4 | GO:0045663 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 6.52e-04 | 95 | 150 | 5 | GO:2000781 | |
| GeneOntologyBiologicalProcess | vascular associated smooth muscle cell differentiation | 6.87e-04 | 55 | 150 | 4 | GO:0035886 | |
| GeneOntologyBiologicalProcess | circulatory system development | SOX6 MYLK MYO1E SYNE1 APC HIF1AN STAT1 PRDM1 CITED2 TBX19 TENM4 SALL1 WDR11 ANGPTL4 SMARCA2 SMARCA4 PXN C3 TBXT ASXL2 PRKDC CTNNB1 | 7.52e-04 | 1442 | 150 | 22 | GO:0072359 |
| GeneOntologyBiologicalProcess | positive regulation of DNA metabolic process | 7.58e-04 | 333 | 150 | 9 | GO:0051054 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 7.73e-04 | 6 | 150 | 2 | GO:1904878 | |
| GeneOntologyBiologicalProcess | telomerase holoenzyme complex assembly | 7.73e-04 | 6 | 150 | 2 | GO:1905323 | |
| GeneOntologyBiologicalProcess | aortic smooth muscle cell differentiation | 7.73e-04 | 6 | 150 | 2 | GO:0035887 | |
| GeneOntologyBiologicalProcess | ketone biosynthetic process | 7.87e-04 | 57 | 150 | 4 | GO:0042181 | |
| GeneOntologyBiologicalProcess | cell differentiation involved in kidney development | 7.87e-04 | 57 | 150 | 4 | GO:0061005 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 8.42e-04 | 338 | 150 | 9 | GO:0045165 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | SOX6 DLG5 MYLK FZD3 COMMD5 APC LAMA3 LAMB3 LAMC2 STAT1 MAPK8IP3 PRDM1 CITED2 TBX19 ABLIM1 SALL1 SMARCA4 TBXT ASXL2 CTNNB1 | 8.96e-04 | 1269 | 150 | 20 | GO:0009887 |
| GeneOntologyBiologicalProcess | chordate embryonic development | SOX6 MYO1E KRT19 FZD3 MAPK8IP3 PRDM1 CITED2 SALL1 BRCA2 SMARCA4 TBXT ASXL2 PRKDC CTNNB1 EN1 ELL | 9.39e-04 | 906 | 150 | 16 | GO:0043009 |
| GeneOntologyBiologicalProcess | thymus development | 1.02e-03 | 61 | 150 | 4 | GO:0048538 | |
| GeneOntologyBiologicalProcess | ketone metabolic process | 1.02e-03 | 279 | 150 | 8 | GO:0042180 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 1.07e-03 | 217 | 150 | 7 | GO:0006941 | |
| GeneOntologyBiologicalProcess | oviduct development | 1.08e-03 | 7 | 150 | 2 | GO:0060066 | |
| GeneOntologyCellularComponent | laminin-5 complex | 1.41e-06 | 4 | 149 | 3 | GO:0005610 | |
| GeneOntologyCellularComponent | adherens junction | 2.19e-05 | 212 | 149 | 9 | GO:0005912 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | STBD1 SYNE1 RGPD1 APC LAMC2 MAGEE1 HIF1AN STAT1 MAPK8IP3 CDKL5 LRPPRC PLA2G4A HSP90AB2P CTNNB1 HSP90AA1 NOS1AP HSP90AA4P HSP90AA2P HSP90AB1 | 3.75e-05 | 934 | 149 | 19 | GO:0048471 |
| GeneOntologyCellularComponent | laminin complex | 4.11e-05 | 10 | 149 | 3 | GO:0043256 | |
| GeneOntologyCellularComponent | main axon | 4.23e-05 | 89 | 149 | 6 | GO:0044304 | |
| GeneOntologyCellularComponent | axon initial segment | 5.13e-05 | 29 | 149 | 4 | GO:0043194 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 6.48e-05 | 96 | 149 | 6 | GO:0070603 | |
| GeneOntologyCellularComponent | growth cone | 6.77e-05 | 245 | 149 | 9 | GO:0030426 | |
| GeneOntologyCellularComponent | dendritic growth cone | 7.45e-05 | 12 | 149 | 3 | GO:0044294 | |
| GeneOntologyCellularComponent | sarcomere | 7.66e-05 | 249 | 149 | 9 | GO:0030017 | |
| GeneOntologyCellularComponent | site of polarized growth | 8.65e-05 | 253 | 149 | 9 | GO:0030427 | |
| GeneOntologyCellularComponent | Z disc | 1.06e-04 | 151 | 149 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | GBAF complex | 1.22e-04 | 14 | 149 | 3 | GO:0140288 | |
| GeneOntologyCellularComponent | Scrib-APC-beta-catenin complex | 1.51e-04 | 3 | 149 | 2 | GO:0034750 | |
| GeneOntologyCellularComponent | myofibril | 1.54e-04 | 273 | 149 | 9 | GO:0030016 | |
| GeneOntologyCellularComponent | I band | 1.91e-04 | 166 | 149 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 2.41e-04 | 290 | 149 | 9 | GO:0043292 | |
| GeneOntologyCellularComponent | T-tubule | 2.54e-04 | 79 | 149 | 5 | GO:0030315 | |
| GeneOntologyCellularComponent | supramolecular fiber | KRT72 KIF21B BIN1 KRT13 KRT17 KRT19 SYNM SYNE1 SPTBN1 CAPN3 KCNAB2 APC WDR47 LRPPRC SCN8A MACF1 KIF3C CTNNB1 DNAH8 NOS1AP | 2.74e-04 | 1179 | 149 | 20 | GO:0099512 |
| GeneOntologyCellularComponent | axonal growth cone | 2.94e-04 | 45 | 149 | 4 | GO:0044295 | |
| GeneOntologyCellularComponent | distal axon | KIF21B BIN1 KCNAB2 APC DCC MAPK8IP3 WDR47 CDKL5 KIF3C HSP90AA1 HSP90AB1 | 2.95e-04 | 435 | 149 | 11 | GO:0150034 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT72 KIF21B BIN1 KRT13 KRT17 KRT19 SYNM SYNE1 SPTBN1 CAPN3 KCNAB2 APC WDR47 LRPPRC SCN8A MACF1 KIF3C CTNNB1 DNAH8 NOS1AP | 2.99e-04 | 1187 | 149 | 20 | GO:0099081 |
| GeneOntologyCellularComponent | lateral element | 3.16e-04 | 19 | 149 | 3 | GO:0000800 | |
| GeneOntologyCellularComponent | ATPase complex | 3.28e-04 | 129 | 149 | 6 | GO:1904949 | |
| GeneOntologyCellularComponent | dendrite terminus | 3.70e-04 | 20 | 149 | 3 | GO:0044292 | |
| GeneOntologyCellularComponent | node of Ranvier | 3.70e-04 | 20 | 149 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | dendrite | KIF21B BIN1 FZD3 SYNE1 APC MAGEE1 STAT1 MAPK8IP3 WDR47 CDKL5 SCN8A XRN1 KIF3C CTNNB1 HSP90AA1 HSP90AB1 | 4.22e-04 | 858 | 149 | 16 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | KIF21B BIN1 FZD3 SYNE1 APC MAGEE1 STAT1 MAPK8IP3 WDR47 CDKL5 SCN8A XRN1 KIF3C CTNNB1 HSP90AA1 HSP90AB1 | 4.33e-04 | 860 | 149 | 16 | GO:0097447 |
| GeneOntologyCellularComponent | sarcolemma | 4.34e-04 | 190 | 149 | 7 | GO:0042383 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 6.11e-04 | 263 | 149 | 8 | GO:0045111 | |
| GeneOntologyCellularComponent | axon | KIF21B BIN1 FZD3 SPTBN1 KCNAB2 APC DCC STAT1 MAPK8IP3 WDR47 CDKL5 SCN2A SCN8A KIF3C HSP90AA1 HSP90AB1 | 6.35e-04 | 891 | 149 | 16 | GO:0030424 |
| GeneOntologyCellularComponent | glutamatergic synapse | KIF21B DLG5 BIN1 FZD3 SPTBN1 KCNAB2 APC SNAP23 CDKL5 TENM4 SCN2A SCN8A CTNNB1 IL1RAP NOS1AP | 7.53e-04 | 817 | 149 | 15 | GO:0098978 |
| GeneOntologyCellularComponent | cell leading edge | MYLK SPTBN1 APC MAPK8IP3 CDKL5 ABLIM1 CTNNA3 PXN MACF1 CTNNB1 PSD4 | 9.36e-04 | 500 | 149 | 11 | GO:0031252 |
| GeneOntologyCellularComponent | postsynapse | KIF21B DLG5 BIN1 SYNE1 SPTBN1 KCNAB2 APC SNAP23 MAGEE1 DCC ZZEF1 CDKL5 ABLIM1 SCN8A MACF1 CTNNB1 NOS1AP | 9.61e-04 | 1018 | 149 | 17 | GO:0098794 |
| GeneOntologyCellularComponent | manchette | 1.02e-03 | 28 | 149 | 3 | GO:0002177 | |
| GeneOntologyCellularComponent | cell-cell junction | DLG5 MYLK MYO1E SYNM APC SNAP23 LAMA3 PARD3B SCN2A CTNNA3 PXN CTNNB1 | 1.10e-03 | 591 | 149 | 12 | GO:0005911 |
| GeneOntologyCellularComponent | SWI/SNF complex | 1.25e-03 | 30 | 149 | 3 | GO:0016514 | |
| GeneOntologyCellularComponent | cell cortex | 1.40e-03 | 371 | 149 | 9 | GO:0005938 | |
| GeneOntologyCellularComponent | chromatin | SOX6 MORC2 HNF4G TRRAP DDB2 STAT1 CITED2 TBX19 SALL1 SMC3 GLYR1 CHD5 SMARCA2 SMARCA4 TBXT ZFHX3 BICRAL PRKDC CTNNB1 EN1 ELL | 1.91e-03 | 1480 | 149 | 21 | GO:0000785 |
| GeneOntologyCellularComponent | bBAF complex | 2.19e-03 | 10 | 149 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | somatodendritic compartment | KIF21B BIN1 FZD3 SYNE1 APC MAGEE1 STAR STAT1 MAPK8IP3 WDR47 CDKL5 SCN8A XRN1 KIF3C CTNNB1 HSP90AA1 HSP90AA4P HSP90AB1 | 2.89e-03 | 1228 | 149 | 18 | GO:0036477 |
| GeneOntologyCellularComponent | nuclear membrane | 3.62e-03 | 349 | 149 | 8 | GO:0031965 | |
| GeneOntologyCellularComponent | beta-catenin destruction complex | 3.74e-03 | 13 | 149 | 2 | GO:0030877 | |
| GeneOntologyCellularComponent | cuticular plate | 3.74e-03 | 13 | 149 | 2 | GO:0032437 | |
| GeneOntologyCellularComponent | fascia adherens | 3.74e-03 | 13 | 149 | 2 | GO:0005916 | |
| GeneOntologyCellularComponent | cell projection membrane | SPTBN1 APC MAPK8IP3 CDKL5 MACF1 CTNNB1 HSP90AA1 PSD4 HSP90AB1 | 3.82e-03 | 431 | 149 | 9 | GO:0031253 |
| GeneOntologyCellularComponent | leading edge membrane | 4.00e-03 | 210 | 149 | 6 | GO:0031256 | |
| GeneOntologyCellularComponent | condensed nuclear chromosome | 4.10e-03 | 91 | 149 | 4 | GO:0000794 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | BIN1 SYNE1 RGPD1 RFC2 TRRAP STAT1 SALL1 BRCA2 PRPF3 CHD5 SMARCA2 SMARCA4 TNKS BICRAL ASXL2 PRKDC CTNNB1 ELL HSP90AB1 | 4.28e-03 | 1377 | 149 | 19 | GO:0140513 |
| GeneOntologyCellularComponent | synaptonemal complex | 4.31e-03 | 46 | 149 | 3 | GO:0000795 | |
| GeneOntologyCellularComponent | synaptonemal structure | 4.31e-03 | 46 | 149 | 3 | GO:0099086 | |
| GeneOntologyCellularComponent | npBAF complex | 4.34e-03 | 14 | 149 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | postsynaptic density | 5.13e-03 | 451 | 149 | 9 | GO:0014069 | |
| GeneOntologyCellularComponent | nBAF complex | 5.67e-03 | 16 | 149 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | Wnt signalosome | 5.67e-03 | 16 | 149 | 2 | GO:1990909 | |
| GeneOntologyCellularComponent | CCR4-NOT complex | 5.67e-03 | 16 | 149 | 2 | GO:0030014 | |
| GeneOntologyCellularComponent | intermediate filament | 5.82e-03 | 227 | 149 | 6 | GO:0005882 | |
| GeneOntologyCellularComponent | heterochromatin | 5.93e-03 | 101 | 149 | 4 | GO:0000792 | |
| GeneOntologyCellularComponent | microtubule associated complex | 5.99e-03 | 161 | 149 | 5 | GO:0005875 | |
| GeneOntologyCellularComponent | lamellipodium | 6.19e-03 | 230 | 149 | 6 | GO:0030027 | |
| GeneOntologyCellularComponent | NuRD complex | 6.40e-03 | 17 | 149 | 2 | GO:0016581 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription repressor complex | 6.40e-03 | 17 | 149 | 2 | GO:0090571 | |
| GeneOntologyCellularComponent | CHD-type complex | 6.40e-03 | 17 | 149 | 2 | GO:0090545 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 6.40e-03 | 17 | 149 | 2 | GO:0001518 | |
| GeneOntologyCellularComponent | nuclear envelope | BIN1 SYNE1 RGPD1 APC LRPPRC ATP11B PLA2G4A TNKS CTNNB1 NOS1AP | 6.95e-03 | 560 | 149 | 10 | GO:0005635 |
| GeneOntologyCellularComponent | asymmetric synapse | 7.30e-03 | 477 | 149 | 9 | GO:0032279 | |
| GeneOntologyCellularComponent | ruffle membrane | 7.49e-03 | 108 | 149 | 4 | GO:0032587 | |
| HumanPheno | Paronychia | 1.32e-06 | 16 | 67 | 5 | HP:0001818 | |
| HumanPheno | Abnormality of the periungual region | 7.50e-06 | 22 | 67 | 5 | HP:0100803 | |
| HumanPheno | Renal tubular epithelial necrosis | 2.13e-05 | 5 | 67 | 3 | HP:0008682 | |
| HumanPheno | Renal necrosis | 2.13e-05 | 5 | 67 | 3 | HP:0032618 | |
| HumanPheno | Pyoderma | 2.13e-05 | 5 | 67 | 3 | HP:0000999 | |
| HumanPheno | Ureterocele | 3.15e-05 | 29 | 67 | 5 | HP:0000070 | |
| HumanPheno | Hypoplastic dermoepidermal hemidesmosomes | 7.33e-05 | 7 | 67 | 3 | HP:0020117 | |
| HumanPheno | Abnormality of the bladder | BIN1 MYLK SYNE1 COPB2 LAMA3 LAMB3 LAMC2 RFC2 MORC2 TRRAP STAR STAT1 MAPK8IP3 BLM SALL1 BRCA2 SMC3 SMARCA2 MACF1 EN1 | 8.55e-05 | 621 | 67 | 20 | HP:0000014 |
| HumanPheno | Abnormal hand morphology | SOX6 DLG5 SYNE1 KCNAB2 APC LAMA3 LAMB3 LAMC2 REV3L RFC2 MORC2 TRRAP LETM1 MAPK8IP3 BLM CITED2 ZNF462 CDKL5 SALL1 BRCA2 WDR11 SMC3 SCN2A SMARCA2 SMARCA4 ASXL2 PRKDC EN1 | 1.06e-04 | 1082 | 67 | 28 | HP:0005922 |
| HumanPheno | Neoplasm of head and neck | 1.21e-04 | 38 | 67 | 5 | HP:0012288 | |
| HumanPheno | Functional abnormality of the bladder | BIN1 SYNE1 COPB2 LAMA3 LAMB3 LAMC2 RFC2 MORC2 TRRAP STAR STAT1 MAPK8IP3 BLM SALL1 BRCA2 SMC3 SMARCA2 MACF1 EN1 | 1.37e-04 | 590 | 67 | 19 | HP:0000009 |
| HumanPheno | Congenital localized absence of skin | 1.73e-04 | 9 | 67 | 3 | HP:0007383 | |
| HumanPheno | Mitten deformity | 1.73e-04 | 9 | 67 | 3 | HP:0004057 | |
| HumanPheno | Recurrent urinary tract infections | 1.84e-04 | 157 | 67 | 9 | HP:0000010 | |
| HumanPheno | Abnormality of the lower urinary tract | BIN1 MYLK SYNE1 SPTBN1 COPB2 KCNAB2 LAMA3 LAMB3 LAMC2 RFC2 MORC2 TRRAP STAR LETM1 STAT1 MAPK8IP3 BLM LRPPRC SALL1 BRCA2 SMC3 SMARCA2 SMARCA4 MACF1 EN1 | 1.89e-04 | 937 | 67 | 25 | HP:0010936 |
| HumanPheno | Anonychia | 2.02e-04 | 66 | 67 | 6 | HP:0001798 | |
| HumanPheno | Urinary tract infections | 2.03e-04 | 159 | 67 | 9 | HP:0000094 | |
| HumanPheno | Urinary bladder inflammation | 2.03e-04 | 159 | 67 | 9 | HP:0100577 | |
| HumanPheno | Abnormal renal morphology | DLG5 MYLK KRT17 MYO1E COPB2 COQ8B KCNAB2 APC LAMA3 LAMB3 LAMC2 DCC RFC2 CCDC141 TRRAP STAT1 FAH CDKL5 SALL1 BRCA2 WDR11 SMC3 SCN2A SMARCA4 C3 TBXT ASXL2 CTNNB1 EN1 NOS1AP | 2.22e-04 | 1252 | 67 | 30 | HP:0012210 |
| HumanPheno | Restricted or repetitive behaviors or interests | SPTBN1 KCNAB2 RFC2 TRRAP LETM1 MAPK8IP3 CDKL5 CELF2 SMC3 CHD5 SCN2A SCN8A SMARCA2 MACF1 | 2.36e-04 | 368 | 67 | 14 | HP:0031432 |
| HumanPheno | Abnormal finger morphology | SOX6 BIN1 MYLK KRT17 SYNE1 SPTBN1 CAPN3 KCNAB2 APC LAMA3 LAMB3 LAMC2 REV3L RFC2 MORC2 TRRAP LETM1 MAPK8IP3 BLM CITED2 ZNF462 CDKL5 SALL1 BRCA2 WDR11 SMC3 SCN2A SMARCA2 SMARCA4 PRKDC CTNNB1 EN1 | 2.36e-04 | 1385 | 67 | 32 | HP:0001167 |
| HumanPheno | Abnormal dermatological laboratory findings | 2.44e-04 | 10 | 67 | 3 | HP:0003340 | |
| HumanPheno | Lamina lucida cleavage | 2.44e-04 | 10 | 67 | 3 | HP:0003341 | |
| HumanPheno | Abnormal bladder morphology | 2.54e-04 | 201 | 67 | 10 | HP:0025487 | |
| HumanPheno | Multicystic kidney dysplasia | 2.66e-04 | 98 | 67 | 7 | HP:0000003 | |
| HumanPheno | Squamous cell carcinoma | 3.02e-04 | 71 | 67 | 6 | HP:0002860 | |
| HumanPheno | Perseverative thought | SPTBN1 KCNAB2 RFC2 TRRAP LETM1 MAPK8IP3 CDKL5 CELF2 SMC3 CHD5 SCN2A SCN8A SMARCA2 MACF1 | 3.03e-04 | 377 | 67 | 14 | HP:0030223 |
| HumanPheno | Blistering by anatomical location | 3.29e-04 | 26 | 67 | 4 | HP:0033800 | |
| HumanPheno | Subepidermal blistering | 3.33e-04 | 11 | 67 | 3 | HP:0033804 | |
| HumanPheno | Abnormal dermoepidermal hemidesmosome morphology | 3.33e-04 | 11 | 67 | 3 | HP:0032449 | |
| HumanPheno | Neonatal seizure | 3.33e-04 | 11 | 67 | 3 | HP:0032807 | |
| HumanPheno | Abnormal stomach morphology | BIN1 KCNAB2 APC LAMA3 LAMB3 LAMC2 DCC RFC2 LETM1 MAPK8IP3 BLM CDKL5 LRPPRC SALL1 CELF2 BRCA2 SMC3 SCN8A SMARCA2 PLA2G4A CTNNB1 | 3.47e-04 | 742 | 67 | 21 | HP:0002577 |
| HumanPheno | Disordered formal thought process | SPTBN1 KCNAB2 RFC2 TRRAP LETM1 MAPK8IP3 CDKL5 CELF2 SMC3 CHD5 SCN2A SCN8A SMARCA2 MACF1 | 3.87e-04 | 386 | 67 | 14 | HP:0025769 |
| HumanPheno | Abnormal dermoepidermal junction morphology | 4.40e-04 | 12 | 67 | 3 | HP:0031538 | |
| HumanPheno | Aplasia/Hypoplasia of the nails | APC LAMA3 LAMB3 LAMC2 RFC2 TRRAP ZNF462 CDKL5 SCN2A SMARCA2 SMARCA4 | 4.65e-04 | 258 | 67 | 11 | HP:0008386 |
| HumanPheno | Hydroureter | 4.70e-04 | 77 | 67 | 6 | HP:0000072 | |
| HumanPheno | Abnormality of the male genitalia | DNHD1 BIN1 MYLK SYNE1 SPTBN1 KCNAB2 APC LAMA3 LAMB3 LAMC2 DCC RFC2 CCDC141 TRRAP DDB2 STAR LETM1 BLM CITED2 ZNF462 CDKL5 LRPPRC SALL1 BRCA2 WDR11 SMC3 PRPF3 SCN2A SMARCA2 SMARCA4 SCP2 PRKDC | 4.89e-04 | 1437 | 67 | 32 | HP:0010461 |
| HumanPheno | Esophageal neoplasm | 5.07e-04 | 29 | 67 | 4 | HP:0100751 | |
| HumanPheno | Tongue tremor | 5.07e-04 | 3 | 67 | 2 | HP:0031947 | |
| HumanPheno | Decreased CSF 5-methyltetrahydrofolate concentration | 5.07e-04 | 3 | 67 | 2 | HP:0012446 | |
| HumanPheno | Esophageal carcinoma | 5.66e-04 | 13 | 67 | 3 | HP:0011459 | |
| HumanPheno | Blistering by histological location | 5.66e-04 | 13 | 67 | 3 | HP:0033801 | |
| HumanPheno | Abnormal thought pattern | SPTBN1 KCNAB2 RFC2 TRRAP LETM1 MAPK8IP3 CDKL5 CELF2 SMC3 CHD5 SCN2A SCN8A SMARCA2 MACF1 | 6.15e-04 | 404 | 67 | 14 | HP:5200269 |
| HumanPheno | Abnormal male external genitalia morphology | DNHD1 BIN1 MYLK SYNE1 SPTBN1 KCNAB2 LAMA3 LAMB3 LAMC2 DCC RFC2 CCDC141 TRRAP DDB2 STAR LETM1 BLM CITED2 ZNF462 CDKL5 LRPPRC SALL1 BRCA2 WDR11 SMC3 PRPF3 SCN2A SMARCA2 SMARCA4 PRKDC | 6.72e-04 | 1329 | 67 | 30 | HP:0000032 |
| MousePheno | increased malignant tumor incidence | SPTBN1 RGPD1 APC CUL9 DCC DDB2 STAT1 FAH BRCA2 SMARCA4 CTNNB1 | 1.51e-05 | 237 | 132 | 11 | MP:0002018 |
| MousePheno | increased carcinoma incidence | 1.73e-05 | 197 | 132 | 10 | MP:0002038 | |
| MousePheno | ectopic manchette | 2.64e-05 | 19 | 132 | 4 | MP:0009377 | |
| MousePheno | abnormal adrenal gland morphology | 5.42e-05 | 181 | 132 | 9 | MP:0000639 | |
| MousePheno | increased classified tumor incidence | SPTBN1 RGPD1 APC CUL9 DCC DDB2 STAT1 BLM FAH BRCA2 SMARCA4 PRKDC CTNNB1 | 6.42e-05 | 381 | 132 | 13 | MP:0010273 |
| MousePheno | decreased level of surface class I molecules | 6.63e-05 | 9 | 132 | 3 | MP:0001841 | |
| MousePheno | abnormal classified tumor incidence | SPTBN1 RGPD1 APC CUL9 DCC DDB2 STAT1 BLM FAH BRCA2 SMARCA4 PRKDC CTNNB1 | 6.95e-05 | 384 | 132 | 13 | MP:0020188 |
| MousePheno | postnatal lethality | SOX6 CDO1 SYNE1 APC LAMA3 LAMB3 LAMC2 STAR PRDM1 CITED2 FAH CELF2 BRCA2 SMC3 GLYR1 SCN2A ANGPTL4 SCN8A SMARCA4 TBXT ZFHX3 ASXL2 PRKDC EN1 | 7.03e-05 | 1084 | 132 | 24 | MP:0002082 |
| MousePheno | increased organ/body region tumor incidence | SPTBN1 RGPD1 APC CUL9 DCC MORC2 STAT1 BLM FAH BRCA2 SMARCA4 PRKDC CTNNB1 | 9.24e-05 | 395 | 132 | 13 | MP:0010274 |
| MousePheno | abnormal organ/body region tumor incidence | SPTBN1 RGPD1 APC CUL9 DCC MORC2 STAT1 BLM FAH BRCA2 SMARCA4 PRKDC CTNNB1 | 1.07e-04 | 401 | 132 | 13 | MP:0013152 |
| MousePheno | decreased airway resistance | 1.28e-04 | 11 | 132 | 3 | MP:0010936 | |
| MousePheno | abnormal level of surface class I molecules | 1.28e-04 | 11 | 132 | 3 | MP:0001839 | |
| MousePheno | abnormal eating behavior | CDO1 BIN1 SYNE1 LRRC32 COPB2 LAMC2 DCC HNF4G HIF1AN SALL1 SCN2A SCP2 C3 ZFHX3 TNKS EN1 | 1.81e-04 | 604 | 132 | 16 | MP:0001431 |
| MousePheno | abnormal antigen presentation via MHC class I | 2.20e-04 | 13 | 132 | 3 | MP:0001836 | |
| Domain | Spectrin | 2.68e-05 | 23 | 144 | 4 | PF00435 | |
| Domain | - | 5.72e-05 | 222 | 144 | 9 | 1.25.10.10 | |
| Domain | Gln-Leu-Gln_QLQ | 5.90e-05 | 2 | 144 | 2 | IPR014978 | |
| Domain | SnAC | 5.90e-05 | 2 | 144 | 2 | PF14619 | |
| Domain | QLQ | 5.90e-05 | 2 | 144 | 2 | SM00951 | |
| Domain | QLQ | 5.90e-05 | 2 | 144 | 2 | PS51666 | |
| Domain | SnAC | 5.90e-05 | 2 | 144 | 2 | SM01314 | |
| Domain | SnAC | 5.90e-05 | 2 | 144 | 2 | IPR029295 | |
| Domain | QLQ | 5.90e-05 | 2 | 144 | 2 | PF08880 | |
| Domain | Spectrin_repeat | 6.93e-05 | 29 | 144 | 4 | IPR002017 | |
| Domain | SPEC | 1.03e-04 | 32 | 144 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.03e-04 | 32 | 144 | 4 | IPR018159 | |
| Domain | Intermediate_filament_CS | 1.25e-04 | 63 | 144 | 5 | IPR018039 | |
| Domain | Heat_shock_protein_90_CS | 1.76e-04 | 3 | 144 | 2 | IPR019805 | |
| Domain | - | 1.76e-04 | 3 | 144 | 2 | 4.10.1130.10 | |
| Domain | Filament | 2.20e-04 | 71 | 144 | 5 | SM01391 | |
| Domain | IF | 2.35e-04 | 72 | 144 | 5 | PS00226 | |
| Domain | Filament | 2.50e-04 | 73 | 144 | 5 | PF00038 | |
| Domain | ARM-like | 2.51e-04 | 270 | 144 | 9 | IPR011989 | |
| Domain | IF | 3.02e-04 | 76 | 144 | 5 | IPR001664 | |
| Domain | HATPase_c | 3.36e-04 | 18 | 144 | 3 | SM00387 | |
| Domain | HSA | 3.51e-04 | 4 | 144 | 2 | SM00573 | |
| Domain | Hsp90_fam | 3.51e-04 | 4 | 144 | 2 | IPR001404 | |
| Domain | Hsp90_N | 3.51e-04 | 4 | 144 | 2 | IPR020575 | |
| Domain | HSP90 | 3.51e-04 | 4 | 144 | 2 | PF00183 | |
| Domain | HSA | 3.51e-04 | 4 | 144 | 2 | PS51204 | |
| Domain | HSP90 | 3.51e-04 | 4 | 144 | 2 | PS00298 | |
| Domain | HSA_dom | 3.51e-04 | 4 | 144 | 2 | IPR014012 | |
| Domain | HSA | 3.51e-04 | 4 | 144 | 2 | PF07529 | |
| Domain | HATPase_c | 3.97e-04 | 19 | 144 | 3 | PF02518 | |
| Domain | - | 4.65e-04 | 20 | 144 | 3 | 3.30.565.10 | |
| Domain | HATPase_C | 5.39e-04 | 21 | 144 | 3 | IPR003594 | |
| Domain | UbiB_dom | 5.81e-04 | 5 | 144 | 2 | IPR004147 | |
| Domain | ABC1 | 5.81e-04 | 5 | 144 | 2 | PF03109 | |
| Domain | ACTININ_2 | 7.10e-04 | 23 | 144 | 3 | PS00020 | |
| Domain | ACTININ_1 | 7.10e-04 | 23 | 144 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 7.10e-04 | 23 | 144 | 3 | IPR001589 | |
| Domain | BRK | 8.68e-04 | 6 | 144 | 2 | SM00592 | |
| Domain | Na_trans_cytopl | 8.68e-04 | 6 | 144 | 2 | PF11933 | |
| Domain | BRK_domain | 8.68e-04 | 6 | 144 | 2 | IPR006576 | |
| Domain | Na_trans_cytopl | 8.68e-04 | 6 | 144 | 2 | IPR024583 | |
| Domain | FAT | 8.68e-04 | 6 | 144 | 2 | PS51189 | |
| Domain | FATC | 8.68e-04 | 6 | 144 | 2 | PS51190 | |
| Domain | FAT | 8.68e-04 | 6 | 144 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 8.68e-04 | 6 | 144 | 2 | IPR003151 | |
| Domain | FATC_dom | 8.68e-04 | 6 | 144 | 2 | IPR003152 | |
| Domain | TF_Brachyury | 8.68e-04 | 6 | 144 | 2 | IPR002070 | |
| Domain | PIK_FAT | 8.68e-04 | 6 | 144 | 2 | IPR014009 | |
| Domain | BRK | 8.68e-04 | 6 | 144 | 2 | PF07533 | |
| Domain | FATC | 8.68e-04 | 6 | 144 | 2 | SM01343 | |
| Domain | APC_su10/DOC_dom | 1.21e-03 | 7 | 144 | 2 | IPR004939 | |
| Domain | DOC | 1.21e-03 | 7 | 144 | 2 | PS51284 | |
| Domain | ANAPC10 | 1.21e-03 | 7 | 144 | 2 | PF03256 | |
| Domain | APC10 | 1.21e-03 | 7 | 144 | 2 | SM01337 | |
| Domain | ARM-type_fold | 1.28e-03 | 339 | 144 | 9 | IPR016024 | |
| Domain | SH3 | 1.45e-03 | 216 | 144 | 7 | PS50002 | |
| Domain | EGF_LAM_2 | 1.56e-03 | 30 | 144 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 1.56e-03 | 30 | 144 | 3 | PS01248 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 1.60e-03 | 8 | 144 | 2 | IPR019565 | |
| Domain | Thiol-ester_cl | 1.60e-03 | 8 | 144 | 2 | PF10569 | |
| Domain | LAMININ_IVA | 1.60e-03 | 8 | 144 | 2 | PS51115 | |
| Domain | Laminin_B | 1.60e-03 | 8 | 144 | 2 | PF00052 | |
| Domain | MacrogloblnA2_CS | 1.60e-03 | 8 | 144 | 2 | IPR019742 | |
| Domain | LamB | 1.60e-03 | 8 | 144 | 2 | SM00281 | |
| Domain | A2M_N_2 | 1.60e-03 | 8 | 144 | 2 | SM01359 | |
| Domain | - | 1.60e-03 | 8 | 144 | 2 | 2.60.40.690 | |
| Domain | A2M_recep | 1.60e-03 | 8 | 144 | 2 | SM01361 | |
| Domain | A2M | 1.60e-03 | 8 | 144 | 2 | SM01360 | |
| Domain | Laminin_IV | 1.60e-03 | 8 | 144 | 2 | IPR000034 | |
| Domain | SH3_domain | 1.61e-03 | 220 | 144 | 7 | IPR001452 | |
| Domain | SNF2_N | 1.89e-03 | 32 | 144 | 3 | IPR000330 | |
| Domain | SNF2_N | 1.89e-03 | 32 | 144 | 3 | PF00176 | |
| Domain | BTK | 2.05e-03 | 9 | 144 | 2 | SM00107 | |
| Domain | PH_dom-spectrin-type | 2.05e-03 | 9 | 144 | 2 | IPR001605 | |
| Domain | Znf_Btk_motif | 2.05e-03 | 9 | 144 | 2 | IPR001562 | |
| Domain | BTK | 2.05e-03 | 9 | 144 | 2 | PF00779 | |
| Domain | ZF_BTK | 2.05e-03 | 9 | 144 | 2 | PS51113 | |
| Domain | HEAT_REPEAT | 2.10e-03 | 70 | 144 | 4 | PS50077 | |
| Domain | TPR-like_helical_dom | 2.23e-03 | 233 | 144 | 7 | IPR011990 | |
| Domain | P-loop_NTPase | KIF21B DNHD1 DLG5 MYO1E RFC2 ABCA8 BLM SMC3 CHD5 SMARCA2 SMARCA4 ABCC12 KIF3C DNAH8 TAP2 | 2.33e-03 | 848 | 144 | 15 | IPR027417 |
| Domain | EGF_Lam | 2.45e-03 | 35 | 144 | 3 | SM00180 | |
| Domain | Laminin_EGF | 2.45e-03 | 35 | 144 | 3 | PF00053 | |
| Domain | Na_channel_asu | 2.55e-03 | 10 | 144 | 2 | IPR001696 | |
| Domain | A2M | 2.55e-03 | 10 | 144 | 2 | PF00207 | |
| Domain | Na_trans_assoc | 2.55e-03 | 10 | 144 | 2 | IPR010526 | |
| Domain | A2M_N_2 | 2.55e-03 | 10 | 144 | 2 | IPR011625 | |
| Domain | A2M_comp | 2.55e-03 | 10 | 144 | 2 | IPR011626 | |
| Domain | A2M_recep | 2.55e-03 | 10 | 144 | 2 | PF07677 | |
| Domain | A2M_comp | 2.55e-03 | 10 | 144 | 2 | PF07678 | |
| Domain | Na_trans_assoc | 2.55e-03 | 10 | 144 | 2 | PF06512 | |
| Domain | A2M_N | 2.55e-03 | 10 | 144 | 2 | PF01835 | |
| Domain | A2M_N | 2.55e-03 | 10 | 144 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 2.55e-03 | 10 | 144 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 2.55e-03 | 10 | 144 | 2 | PS00477 | |
| Domain | A2M_N_2 | 2.55e-03 | 10 | 144 | 2 | PF07703 | |
| Domain | Macroglobln_a2 | 2.55e-03 | 10 | 144 | 2 | IPR001599 | |
| Domain | Laminin_EGF | 3.11e-03 | 38 | 144 | 3 | IPR002049 | |
| Domain | SH3_9 | 3.11e-03 | 78 | 144 | 4 | PF14604 | |
| Domain | - | 3.70e-03 | 12 | 144 | 2 | 1.50.10.20 | |
| Domain | SH3_2 | 4.41e-03 | 86 | 144 | 4 | PF07653 | |
| Pathway | WP_RETT_SYNDROME | 2.06e-06 | 48 | 112 | 6 | M39759 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | FZD3 APC LAMA3 LAMB3 LAMC2 DCC STAT1 BRCA2 CTNNA3 CTNNB1 HSP90AA1 HSP90AB1 | 1.03e-05 | 325 | 112 | 12 | M12868 |
| Pathway | REACTOME_METABOLISM_OF_COFACTORS | 4.20e-05 | 25 | 112 | 4 | M27855 | |
| Pathway | REACTOME_METABOLISM_OF_COFACTORS | 4.20e-05 | 25 | 112 | 4 | MM15574 | |
| Pathway | WP_CANCER_PATHWAYS | FZD3 APC LAMA3 LAMB3 LAMC2 DCC DDB2 STAT1 GSTA3 BRCA2 CTNNA3 CTNNB1 HSP90AA1 HSP90AB1 | 4.79e-05 | 507 | 112 | 14 | M48302 |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 7.69e-05 | 11 | 112 | 3 | M27372 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 7.69e-05 | 11 | 112 | 3 | M158 | |
| Pathway | REACTOME_UBIQUINOL_BIOSYNTHESIS | 1.32e-04 | 13 | 112 | 3 | M27142 | |
| Pathway | REACTOME_UBIQUINOL_BIOSYNTHESIS | 1.32e-04 | 13 | 112 | 3 | MM17216 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 2.07e-04 | 15 | 112 | 3 | M27161 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 2.07e-04 | 15 | 112 | 3 | MM1439 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 2.34e-04 | 155 | 112 | 7 | M522 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 2.54e-04 | 16 | 112 | 3 | M8516 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 2.63e-04 | 158 | 112 | 7 | MM14791 | |
| Pathway | WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS | 3.06e-04 | 17 | 112 | 3 | M39525 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 3.36e-04 | 117 | 112 | 6 | M19248 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 4.33e-04 | 80 | 112 | 5 | M223 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | COPB2 CUL9 REV3L MORC2 TRRAP HIF1AN STAT1 WDR47 BLM SALL1 SMC3 GLYR1 A2ML1 SMARCA4 PLA2G4A UTP20 ASXL2 CTNNB1 ANKRD52 HSP90AA1 HSP90AB1 | 1.69e-10 | 857 | 151 | 21 | 25609649 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | KRT72 DLG5 KRT13 KRT17 MYO1E SYNM SPTBN1 LAMA3 LAMB3 LAMC2 RFC2 ABLIM1 LRPPRC WDR11 SMC3 PRPF3 GLYR1 CHD5 SMARCA4 UTP20 C3 PRKDC CTNNB1 HSP90AA1 HSP90AB1 | 2.12e-10 | 1257 | 151 | 25 | 36526897 |
| Pubmed | SOX6 SESTD1 BIN1 MYO1E SYNM SYNE1 SPTBN1 KCNAB2 APC CUL9 PSMD1 REV3L STAT1 MAPK8IP3 WDR47 VPS9D1 ABLIM1 HEATR6 SGSM2 SMARCA4 MACF1 TNKS PRKDC HSP90AA1 HSP90AB1 | 3.34e-10 | 1285 | 151 | 25 | 35914814 | |
| Pubmed | KRT13 KRT17 KRT19 SYNE1 SPTBN1 APC LAMA3 PSMD1 STAT1 ABLIM1 SMC3 MACF1 BICRAL PRKDC HSP90AA1 HSP90AB1 | 4.51e-10 | 486 | 151 | 16 | 20936779 | |
| Pubmed | SOX6 CNOT11 CNOT10 SPTBN1 COPB2 RGPD1 CUL9 PSMD1 MORC2 TRRAP STAT1 PRDM1 BLM ZNF462 SALL1 SMC3 GLYR1 CHD5 XRN1 SMARCA2 SMARCA4 TBXT ZFHX3 ASXL2 EN1 | 2.90e-09 | 1429 | 151 | 25 | 35140242 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SPTBN1 COPB2 PSMD1 RFC2 TRRAP STAT1 WDR47 BLM LRPPRC WDR11 SMC3 PRPF3 GLYR1 A2ML1 XRN1 SMARCA2 SMARCA4 MACF1 UTP20 PRKDC HSP90AB2P ANKRD52 HSP90AA1 HSP90AB1 | 4.79e-09 | 1353 | 151 | 24 | 29467282 |
| Pubmed | BIN1 KRT17 SYNE1 SPTBN1 CAPN3 PSMD1 CCDC141 ZNF462 ABLIM1 LRPPRC PXN MACF1 TNKS HSP90AA1 HSP90AB1 | 5.24e-09 | 497 | 151 | 15 | 23414517 | |
| Pubmed | The HSP90 family of genes in the human genome: insights into their divergence and evolution. | 6.07e-09 | 16 | 151 | 5 | 16269234 | |
| Pubmed | KIF21B SESTD1 BIN1 SYNE1 SPTBN1 RGPD1 KCNAB2 APC LETM1 MAPK8IP3 WDR47 ZNF462 ABLIM1 LRPPRC SMARCA4 MACF1 TNKS CTNNB1 HSP90AA1 HSP90AB1 | 7.92e-09 | 963 | 151 | 20 | 28671696 | |
| Pubmed | Stat1 mediates an auto-regulation of hsp90beta gene in heat shock response. | 1.18e-08 | 7 | 151 | 4 | 20353823 | |
| Pubmed | DLG5 STBD1 SPTBN1 COPB2 APC PSMD1 LETM1 STAT1 ABLIM1 LRPPRC SMC3 ZC3HAV1L XRN1 MACF1 PRKDC HSP90AA1 HSP90AB1 | 1.42e-08 | 708 | 151 | 17 | 39231216 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | SESTD1 CUL9 ZZEF1 TRRAP HIF1AN LRPPRC COQ8A SMC3 XRN1 ANKRD52 | 3.40e-08 | 212 | 151 | 10 | 33853758 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | DLG5 MYO1E SYNE1 SPTBN1 COPB2 ABLIM1 LRPPRC SMC3 PRPF3 GLYR1 CHD5 SMARCA4 UTP20 C3 PRKDC HSP90AA1 HSP90AA4P HSP90AA2P HSP90AB1 | 3.44e-08 | 949 | 151 | 19 | 36574265 |
| Pubmed | 5.24e-08 | 222 | 151 | 10 | 37071664 | ||
| Pubmed | KRT72 BIN1 MYO1E KRT19 SYNE1 SPTBN1 COPB2 KCNAB2 APC LETM1 MAPK8IP3 WDR47 CDKL5 ABLIM1 LRPPRC TENM4 SCN2A XRN1 SMARCA4 MACF1 CTNNB1 HSP90AA1 HSP90AB1 | 6.30e-08 | 1431 | 151 | 23 | 37142655 | |
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 15373767 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 18550790 | ||
| Pubmed | Laminin-5 suppresses chondrogenic differentiation of murine teratocarcinoma cell line ATDC5. | 8.02e-08 | 3 | 151 | 3 | 16165127 | |
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 8113417 | ||
| Pubmed | Synthetic D-amino acid peptide inhibits tumor cell motility on laminin-5. | 8.02e-08 | 3 | 151 | 3 | 16537560 | |
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 8012114 | ||
| Pubmed | Laminin-332 (Laminin-5) is the major motility ligand for B cell chronic lymphocytic leukemia. | 8.02e-08 | 3 | 151 | 3 | 17482449 | |
| Pubmed | Expression and chain assembly of human laminin-332 in an insect cell-free translation system. | 8.02e-08 | 3 | 151 | 3 | 18603785 | |
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 33179081 | ||
| Pubmed | Quantitative analysis of laminin 5 gene expression in human keratinocytes. | 8.02e-08 | 3 | 151 | 3 | 15854126 | |
| Pubmed | Uncoordinated production of Laminin-5 chains in airways epithelium of allergic asthmatics. | 8.02e-08 | 3 | 151 | 3 | 16179086 | |
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 27375110 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 22563463 | ||
| Pubmed | Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice. | 8.02e-08 | 3 | 151 | 3 | 8833897 | |
| Pubmed | Fibroblasts contribute to the deposition of laminin 5 in the extracellular matrix. | 8.02e-08 | 3 | 151 | 3 | 15149852 | |
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 17137774 | ||
| Pubmed | Differential expression of laminin-5 subunits during incisor and molar development in the mouse. | 8.02e-08 | 3 | 151 | 3 | 10853832 | |
| Pubmed | Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. | 1.10e-07 | 87 | 151 | 7 | 17148452 | |
| Pubmed | BIN1 SPTBN1 COPB2 RGPD1 KCNAB2 APC PSMD1 MAPK8IP3 WDR47 CDKL5 ABLIM1 LRPPRC TENM4 GLYR1 XRN1 MACF1 CTNNB1 HSP90AA1 NOS1AP HSP90AB1 | 1.23e-07 | 1139 | 151 | 20 | 36417873 | |
| Pubmed | 1.42e-07 | 187 | 151 | 9 | 26460568 | ||
| Pubmed | SPTBN1 COPB2 CUL9 PSMD1 TRRAP BLM LRPPRC GLYR1 XRN1 SMARCA2 SMARCA4 MACF1 UTP20 PRKDC ANKRD52 | 1.86e-07 | 653 | 151 | 15 | 22586326 | |
| Pubmed | KRT72 KRT13 MYLK KRT17 PCDHGC5 KRT19 SYNE1 SPTBN1 RGPD1 PSMD1 DCC LETM1 LRPPRC GSTK1 FAM186A CHD5 XRN1 MACF1 PRKDC DNAH8 HSP90AA1 HSP90AB1 | 3.06e-07 | 1442 | 151 | 22 | 35575683 | |
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 8081888 | ||
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 10651091 | ||
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 3.20e-07 | 4 | 151 | 3 | 19091768 | |
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 21034821 | ||
| Pubmed | Bisecting GlcNAc residues on laminin-332 down-regulate galectin-3-dependent keratinocyte motility. | 3.20e-07 | 4 | 151 | 3 | 19940114 | |
| Pubmed | Mapping of the gene family for human heat-shock protein 90 alpha to chromosomes 1, 4, 11, and 14. | 3.20e-07 | 4 | 151 | 3 | 1740332 | |
| Pubmed | Bone morphogenetic protein 1 is an extracellular processing enzyme of the laminin 5 gamma 2 chain. | 3.20e-07 | 4 | 151 | 3 | 10806203 | |
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 22673183 | ||
| Pubmed | HSP90 is necessary for the ACK1-dependent phosphorylation of STAT1 and STAT3. | 3.30e-07 | 14 | 151 | 4 | 28739485 | |
| Pubmed | SPTBN1 PSMD1 RFC2 TRRAP LRPPRC SMC3 ANGPTL4 PRKDC HSP90AA1 HSP90AB1 | 3.45e-07 | 272 | 151 | 10 | 31010829 | |
| Pubmed | 4.05e-07 | 65 | 151 | 6 | 23453885 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | KRT17 KRT19 CNOT10 APC PSMD1 RFC2 TRRAP DDB2 HIF1AN LRPPRC SMC3 PRPF3 SMARCA2 ABCC12 TNKS ASXL2 ANKRD52 ELL | 4.16e-07 | 1005 | 151 | 18 | 19615732 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | KRT13 KRT17 KRT19 SPTBN1 SMC3 PRPF3 GLYR1 CHD5 SMARCA2 SMARCA4 ZFHX3 PRKDC HSP90AA1 HSP90AB1 | 4.45e-07 | 605 | 151 | 14 | 28977666 |
| Pubmed | Sonic hedgehog-dependent activation of Gli2 is essential for embryonic hair follicle development. | 5.97e-07 | 16 | 151 | 4 | 12533516 | |
| Pubmed | KRT72 KRT13 STBD1 KRT17 KRT19 COPB2 PSMD1 LRPPRC SMC3 PRPF3 GLYR1 CHD5 MACF1 PRKDC HSP90AB2P HSP90AA1 HSP90AA4P HSP90AA2P HSP90AB1 | 6.80e-07 | 1153 | 151 | 19 | 29845934 | |
| Pubmed | 7.97e-07 | 5 | 151 | 3 | 16728390 | ||
| Pubmed | Laminin 5 regulates polycystic kidney cell proliferation and cyst formation. | 7.97e-07 | 5 | 151 | 3 | 16870608 | |
| Pubmed | 7.97e-07 | 5 | 151 | 3 | 14612440 | ||
| Pubmed | IAP insertion in the murine LamB3 gene results in junctional epidermolysis bullosa. | 7.97e-07 | 5 | 151 | 3 | 9271670 | |
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 7.97e-07 | 5 | 151 | 3 | 17855024 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 9.98e-07 | 120 | 151 | 7 | 31413325 | |
| Pubmed | 1.22e-06 | 43 | 151 | 5 | 36950384 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CDO1 BIN1 SPTBN1 PSMD1 MORC2 TRRAP MAPK8IP3 BLM ABLIM1 SMARCA2 SMARCA4 PLA2G4A UTP20 PRKDC HSP90AB1 | 1.56e-06 | 774 | 151 | 15 | 15302935 |
| Pubmed | Expression and localization of laminin-5 subunits in the mouse incisor. | 1.59e-06 | 6 | 151 | 3 | 9506922 | |
| Pubmed | 1.59e-06 | 6 | 151 | 3 | 20301304 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | SPTBN1 COPB2 PSMD1 RFC2 BLM SMC3 PRPF3 SMARCA2 SMARCA4 MACF1 PRKDC HSP90AA1 HSP90AB1 | 1.73e-06 | 582 | 151 | 13 | 20467437 |
| Pubmed | COQ8B CUL9 REV3L RFC2 ZZEF1 TRRAP ABCA8 COQ8A PRPF3 CHD5 XRN1 SMARCA2 SMARCA4 MACF1 ZFHX3 BICRAL ANKRD52 NOS1AP | 1.85e-06 | 1116 | 151 | 18 | 31753913 | |
| Pubmed | Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk. | 1.86e-06 | 84 | 151 | 6 | 19237606 | |
| Pubmed | SCFD2 DLG5 KRT13 STBD1 SYNM SYNE1 WWP2 SPTBN1 SNAP23 LETM1 BLM LRPPRC AIFM2 WDR11 GLYR1 MACF1 PNPLA8 CTNNB1 ANKRD52 QRSL1 NOS1AP | 2.00e-06 | 1487 | 151 | 21 | 33957083 | |
| Pubmed | E3 Ligase Trim21 Ubiquitylates and Stabilizes Keratin 17 to Induce STAT3 Activation in Psoriasis. | 2.20e-06 | 135 | 151 | 7 | 29859926 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | KRT17 SYNE1 SNAP23 PSMD1 RFC2 TRRAP STAT1 ABLIM1 LRPPRC SMC3 PRPF3 SMARCA4 MACF1 UTP20 PRKDC CTNNB1 HSP90AB1 | 2.48e-06 | 1024 | 151 | 17 | 24711643 |
| Pubmed | SOX6 ZNF438 STAT1 PRDM1 CITED2 ZNF462 TBX19 ABLIM1 SALL1 GLYR1 SMARCA2 PXN TBXT ZFHX3 CTNNB1 | 2.64e-06 | 808 | 151 | 15 | 20412781 | |
| Pubmed | A switch from hBrm to Brg1 at IFNγ-activated sequences mediates the activation of human genes. | 2.77e-06 | 7 | 151 | 3 | 21079652 | |
| Pubmed | SPTBN1 ABLIM1 LRPPRC SMC3 PRPF3 SMARCA4 CTNNB1 HSP90AA1 HSP90AB1 | 3.41e-06 | 274 | 151 | 9 | 34244482 | |
| Pubmed | CNOT10 WWP2 PSMD1 LRRC8D LRPPRC ATP11B GSTK1 WDR11 CHD5 XRN1 SMARCA4 SCP2 PRKDC IL1RAP TAP2 HSP90AA1 PSD4 HSP90AB1 | 3.49e-06 | 1168 | 151 | 18 | 19946888 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | CNOT11 KRT13 KRT17 MYO1E SPTBN1 COPB2 PSMD1 RFC2 LRRC8D LETM1 LRPPRC SMC3 PRPF3 ZC3HAV1L SMARCA4 MACF1 PRKDC HSP90AB2P HSP90AA1 HSP90AB1 | 3.54e-06 | 1415 | 151 | 20 | 28515276 |
| Pubmed | Expression and localization of laminin-5 subunits during mouse tooth development. | 4.42e-06 | 8 | 151 | 3 | 9489770 | |
| Pubmed | Spatial and temporal control of laminin-332 and -511 expressions during hair morphogenesis. | 4.42e-06 | 8 | 151 | 3 | 23529140 | |
| Pubmed | 4.42e-06 | 8 | 151 | 3 | 25069779 | ||
| Pubmed | KRT72 KRT17 SYNM SPTBN1 PSMD1 LRPPRC SMC3 MACF1 HSP90AB2P HSP90AA1 HSP90AA2P HSP90AB1 | 4.45e-06 | 538 | 151 | 12 | 28524877 | |
| Pubmed | 4.56e-06 | 284 | 151 | 9 | 29459677 | ||
| Pubmed | 4.63e-06 | 151 | 151 | 7 | 17043677 | ||
| Pubmed | 4.87e-06 | 99 | 151 | 6 | 34161765 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | DLG5 KRT19 RGPD1 APC SNAP23 PARD3B RIMBP3 BRCA2 WDR11 XRN1 PXN ANKRD52 ELL HSP90AA1 HSP90AB1 | 5.07e-06 | 853 | 151 | 15 | 28718761 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | BIN1 KRT17 MYO1E SPTBN1 COPB2 PSMD1 SCLY RFC2 ZZEF1 DDB2 STAT1 ASB6 PXN PLA2G4A MACF1 PRKDC HSP90AB2P HSP90AA1 HSP90AA4P HSP90AB1 | 5.35e-06 | 1455 | 151 | 20 | 22863883 |
| Pubmed | USP7 controls NGN3 stability and pancreatic endocrine lineage development. | 5.49e-06 | 58 | 151 | 5 | 37117185 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 5.77e-06 | 220 | 151 | 8 | 35785414 | |
| Pubmed | KRT17 SPTBN1 PSMD1 RFC2 BLM LRPPRC BRCA2 SMC3 PRPF3 C3 PRKDC HSP90AA1 HSP90AB1 | 5.91e-06 | 652 | 151 | 13 | 31180492 | |
| Pubmed | 6.48e-06 | 104 | 151 | 6 | 36055981 | ||
| Pubmed | 6.61e-06 | 9 | 151 | 3 | 12482924 | ||
| Pubmed | 6.80e-06 | 225 | 151 | 8 | 25277244 | ||
| Pubmed | A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. | 7.34e-06 | 162 | 151 | 7 | 14743216 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | WWP2 LAMA3 PSMD1 PARD3B TRRAP LRRC8D MAPK8IP3 ZNF462 ABLIM1 LRPPRC ATP11B COQ8A WDR11 PRPF3 SGSM2 GLYR1 SMARCA2 SCP2 MACF1 ZFHX3 | 7.52e-06 | 1489 | 151 | 20 | 28611215 |
| Pubmed | DLG5 CNOT11 CNOT10 SYNE1 APC SNAP23 RFC2 MORC2 TRRAP STAT1 BLM ABLIM1 WDR11 XRN1 SMARCA2 PXN MACF1 UTP20 ZFHX3 HSP90AB2P | 8.13e-06 | 1497 | 151 | 20 | 31527615 | |
| Pubmed | DLG5 WWP2 SPTBN1 COPB2 APC PSMD1 STAT1 ABLIM1 LRPPRC GSTK1 SMC3 XRN1 SMARCA2 PXN PRKDC CTNNB1 HSP90AA1 HSP90AB1 | 8.53e-06 | 1247 | 151 | 18 | 27684187 | |
| Pubmed | 9.41e-06 | 10 | 151 | 3 | 28125198 | ||
| Pubmed | 9.41e-06 | 10 | 151 | 3 | 9034910 | ||
| Pubmed | BAG-2 acts as an inhibitor of the chaperone-associated ubiquitin ligase CHIP. | 9.41e-06 | 10 | 151 | 3 | 16207813 | |
| Pubmed | 9.41e-06 | 10 | 151 | 3 | 11839798 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 9.44e-06 | 394 | 151 | 10 | 27248496 | |
| Pubmed | TRIM29 regulates the assembly of DNA repair proteins into damaged chromatin. | 9.81e-06 | 31 | 151 | 4 | 26095369 | |
| Pubmed | KRT13 KRT17 KRT19 SPTBN1 LAMA3 LAMB3 LAMC2 MACF1 PRKDC HSP90AA1 HSP90AB1 | 1.02e-05 | 488 | 151 | 11 | 31324722 | |
| Pubmed | 1.04e-05 | 66 | 151 | 5 | 23275444 | ||
| Interaction | APC interactions | KRT13 KRT17 KRT19 SYNE1 SPTBN1 APC LAMA3 PSMD1 DCC CDKL5 SMC3 CTNNA3 PXN PLA2G4A MACF1 TNKS CTNNB1 | 4.76e-09 | 389 | 149 | 17 | int:APC |
| Interaction | KCNA3 interactions | DNHD1 DLG5 STBD1 SPTBN1 COPB2 KCNAB2 APC PSMD1 MORC2 LETM1 STAT1 ABLIM1 LRPPRC SMC3 ZC3HAV1L CTNNA3 XRN1 SMARCA4 MACF1 PRKDC HSP90AA1 HSP90AB1 | 4.57e-07 | 871 | 149 | 22 | int:KCNA3 |
| Interaction | EPAS1 interactions | CNOT10 APC PSMD1 TRRAP SMARCA2 SMARCA4 ZFHX3 PRKDC CTNNB1 HSP90AA1 | 6.54e-07 | 173 | 149 | 10 | int:EPAS1 |
| Interaction | CTNNB1 interactions | SOX6 DLG5 KRT19 WWP2 APC SNAP23 PSMD1 PARD3B TRRAP STAT1 CDKL5 LRPPRC SALL1 CTNNA3 SMARCA4 PXN ABCC12 TNKS ASXL2 PRKDC CTNNB1 HSP90AA1 HSP90AB1 | 1.43e-06 | 1009 | 149 | 23 | int:CTNNB1 |
| Interaction | ANKK1 interactions | 3.01e-06 | 31 | 149 | 5 | int:ANKK1 | |
| Interaction | RPS6KA5 interactions | 1.19e-05 | 144 | 149 | 8 | int:RPS6KA5 | |
| Interaction | CDK9 interactions | MYO1E KRT19 WWP2 SPTBN1 COPB2 APC TRRAP STAT1 ABLIM1 BRCA2 SMC3 PRKDC CTNNB1 ELL HSP90AA1 HSP90AA4P HSP90AB1 | 1.30e-05 | 685 | 149 | 17 | int:CDK9 |
| Interaction | RUVBL2 interactions | MYO1E WWP2 APC PSMD1 TRRAP ZNF462 LRPPRC BRCA2 PLA2G4A ASXL2 PRKDC HSP90AB2P CTNNB1 HSP90AA1 HSP90AA2P HSP90AB1 | 1.36e-05 | 616 | 149 | 16 | int:RUVBL2 |
| Interaction | TNK2 interactions | KIF21B BIN1 WWP2 SPTBN1 PSMD1 STAT1 HSP90AB2P HSP90AA1 HSP90AB1 | 1.50e-05 | 195 | 149 | 9 | int:TNK2 |
| Interaction | SOX2 interactions | SOX6 DLG5 KRT13 MYO1E WWP2 SPTBN1 SNAP23 LAMA3 CUL9 RFC2 ZNF462 SALL1 SMC3 CROCC2 GLYR1 A2ML1 XRN1 SMARCA2 SMARCA4 MACF1 C3 ZFHX3 HSP90AB2P CTNNB1 HSP90AA1 HSP90AB1 | 1.53e-05 | 1422 | 149 | 26 | int:SOX2 |
| Interaction | GAN interactions | KIF21B DNHD1 DLG5 KRT17 SYNE1 ZZEF1 TRRAP DNAH8 HSP90AA1 HSP90AB1 | 1.93e-05 | 253 | 149 | 10 | int:GAN |
| Interaction | EFTUD2 interactions | CNOT11 KRT13 KRT17 MYO1E WWP2 SPTBN1 COPB2 CUL9 PSMD1 RFC2 LRRC8D LETM1 LRPPRC GSTK1 SMC3 PRPF3 ZC3HAV1L SMARCA2 SMARCA4 MACF1 ASXL2 PRKDC HSP90AB2P CTNNB1 HSP90AA1 HSP90AB1 | 2.12e-05 | 1449 | 149 | 26 | int:EFTUD2 |
| Interaction | CIT interactions | MYO1E SYNE1 SPTBN1 COPB2 HEATR5A RFC2 ZZEF1 TRRAP ABLIM1 LRPPRC SMC3 PRPF3 GLYR1 SMARCA2 SMARCA4 MACF1 UTP20 PNPLA8 PRKDC HSP90AB2P CTNNB1 CCDC180 HSP90AA1 HSP90AA4P HSP90AA2P HSP90AB1 | 2.15e-05 | 1450 | 149 | 26 | int:CIT |
| Interaction | HDAC1 interactions | SOX6 WWP2 APC PSMD1 DDB2 HIF1AN STAT1 PRDM1 LRPPRC SALL1 BRCA2 SMC3 CHD5 XRN1 SMARCA2 SMARCA4 PXN ZFHX3 CTNNB1 ELL HSP90AA1 HSP90AB1 | 2.20e-05 | 1108 | 149 | 22 | int:HDAC1 |
| Interaction | STAT3 interactions | KRT17 WWP2 LRRC32 COPB2 RGPD1 HIF1AN STAT1 SMARCA4 PLA2G4A ZFHX3 IL1RAP HSP90AA1 HSP90AB1 | 2.80e-05 | 446 | 149 | 13 | int:STAT3 |
| Interaction | METTL22 interactions | 3.78e-05 | 26 | 149 | 4 | int:METTL22 | |
| Interaction | COQ3 interactions | 4.45e-05 | 53 | 149 | 5 | int:COQ3 | |
| Interaction | TEAD1 interactions | 5.05e-05 | 176 | 149 | 8 | int:TEAD1 | |
| Interaction | TERF1 interactions | DLG5 DDB2 BLM SALL1 BRCA2 ZC3HAV1L TNKS PRKDC HSP90AB2P HSP90AA1 HSP90AB1 | 5.60e-05 | 347 | 149 | 11 | int:TERF1 |
| Interaction | FBP1 interactions | KRT72 BIN1 KRT17 MYO1E KCNAB2 APC DCC LRPPRC SMARCA2 PRKDC HSP90AB1 | 5.75e-05 | 348 | 149 | 11 | int:FBP1 |
| Interaction | MGMT interactions | 6.24e-05 | 92 | 149 | 6 | int:MGMT | |
| Interaction | CAD interactions | WWP2 PSMD1 HIF1AN TBX19 LRPPRC COQ8A SMC3 SMARCA4 TBXT ASXL2 CTNNB1 HSP90AA1 | 6.66e-05 | 418 | 149 | 12 | int:CAD |
| Interaction | KDM1A interactions | SOX6 DLG5 KRT17 KRT19 APC PSMD1 TRRAP HIF1AN PRDM1 ZNF462 BRCA2 GLYR1 XRN1 SMARCA2 PXN TBXT ZFHX3 CTNNB1 ANKRD52 | 6.74e-05 | 941 | 149 | 19 | int:KDM1A |
| Interaction | FANCE interactions | 6.77e-05 | 30 | 149 | 4 | int:FANCE | |
| Interaction | HSPB1 interactions | KRT72 MYLK KRT17 WWP2 SPTBN1 PSMD1 TRRAP LETM1 ASB6 SMARCA2 SMARCA4 PXN PRKDC CTNNB1 HSP90AA1 HSP90AB1 | 7.24e-05 | 708 | 149 | 16 | int:HSPB1 |
| Interaction | KRT72 interactions | 7.50e-05 | 59 | 149 | 5 | int:KRT72 | |
| Interaction | CDCA5 interactions | 8.29e-05 | 140 | 149 | 7 | int:CDCA5 | |
| Interaction | CFTR interactions | KRT72 KRT13 KRT17 KRT19 WWP2 SPTBN1 COPB2 RGPD1 APC SNAP23 LAMA3 LAMB3 PSMD1 LAMC2 RFC2 PRDM1 ZNF462 LRPPRC MACF1 C3 PRKDC CTNNB1 TAP2 HSP90AA1 HSP90AB1 | 8.35e-05 | 1480 | 149 | 25 | int:CFTR |
| Interaction | NEIL3 interactions | 8.39e-05 | 97 | 149 | 6 | int:NEIL3 | |
| Interaction | STMN2 interactions | 8.39e-05 | 97 | 149 | 6 | int:STMN2 | |
| Interaction | DISC1 interactions | SYNM SYNE1 SPTBN1 CCDC141 WDR11 SMC3 PRPF3 GLYR1 CTNNA3 MACF1 TNKS KIF3C | 8.52e-05 | 429 | 149 | 12 | int:DISC1 |
| Interaction | BTG3 interactions | 8.88e-05 | 98 | 149 | 6 | int:BTG3 | |
| Interaction | PAX6 interactions | MORC2 ZNF462 SALL1 SMC3 GLYR1 CTNNA3 SMARCA2 SMARCA4 ZFHX3 ASXL2 EN1 | 9.01e-05 | 366 | 149 | 11 | int:PAX6 |
| Interaction | KIF20A interactions | ZNF438 MYO1E SYNE1 SPTBN1 COPB2 MORC2 TRRAP BLM ZNF462 ABLIM1 LRPPRC XRN1 SMARCA2 SMARCA4 MACF1 TNKS PRKDC CTNNB1 HSP90AA2P HSP90AB1 | 9.78e-05 | 1052 | 149 | 20 | int:KIF20A |
| Interaction | ECT2 interactions | MYO1E SPTBN1 PSMD1 RFC2 TRRAP BLM ABLIM1 LRPPRC GSTK1 CTNNA3 MACF1 UTP20 PRKDC HSP90AB2P CTNNB1 HSP90AA4P HSP90AA2P HSP90AB1 | 9.98e-05 | 887 | 149 | 18 | int:ECT2 |
| Interaction | LAMA3 interactions | 1.03e-04 | 63 | 149 | 5 | int:LAMA3 | |
| Interaction | PRC1 interactions | MYO1E SYNE1 WWP2 SPTBN1 APC PSMD1 LAMC2 ZZEF1 TRRAP LRPPRC GLYR1 CHD5 UTP20 PNPLA8 PRKDC CTNNB1 HSP90AA4P HSP90AA2P HSP90AB1 | 1.05e-04 | 973 | 149 | 19 | int:PRC1 |
| Interaction | TTI1 interactions | 1.05e-04 | 101 | 149 | 6 | int:TTI1 | |
| Interaction | HIF1A interactions | RFC2 TRRAP HIF1AN CITED2 LRPPRC SMARCA2 SMARCA4 PRKDC CTNNB1 ELL HSP90AA1 HSP90AB1 | 1.10e-04 | 441 | 149 | 12 | int:HIF1A |
| Interaction | REV1 interactions | 1.26e-04 | 35 | 149 | 4 | int:REV1 | |
| Interaction | ABL1 interactions | 1.36e-04 | 259 | 149 | 9 | int:ABL1 | |
| Interaction | FGD5 interactions | 1.56e-04 | 207 | 149 | 8 | int:FGD5 | |
| Interaction | CHD3 interactions | SOX6 KRT17 KRT19 SPTBN1 SALL1 SMC3 PRPF3 SGSM2 GLYR1 CHD5 SMARCA2 SMARCA4 ZFHX3 PRKDC HSP90AA1 HSP90AB1 | 1.57e-04 | 757 | 149 | 16 | int:CHD3 |
| Interaction | AURKB interactions | ZNF438 DLG5 MYO1E HEATR5A ZZEF1 TRRAP LRPPRC BRCA2 PRPF3 MACF1 PRKDC CTNNB1 HSP90AA1 HSP90AA4P HSP90AA2P HSP90AB1 | 1.66e-04 | 761 | 149 | 16 | int:AURKB |
| Interaction | PRKG2 interactions | 1.69e-04 | 15 | 149 | 3 | int:PRKG2 | |
| Interaction | WDR5 interactions | MYLK KRT17 MYO1E KRT19 WWP2 SPTBN1 COPB2 PSMD1 TRRAP DDB2 ZNF462 LRPPRC SMARCA2 MACF1 C3 ASXL2 PRKDC CTNNB1 HSP90AA1 HSP90AB1 | 1.80e-04 | 1101 | 149 | 20 | int:WDR5 |
| Interaction | COPS5 interactions | KRT13 KRT17 SPTBN1 APC RFC2 HNF4G DDB2 STAT1 BLM SLFN12L SMC3 ASB6 ZC3HAV1L SMARCA4 PRKDC HSP90AB2P CTNNB1 HSP90AA1 HSP90AA2P HSP90AB1 | 1.82e-04 | 1102 | 149 | 20 | int:COPS5 |
| Interaction | CDKL5 interactions | 1.95e-04 | 113 | 149 | 6 | int:CDKL5 | |
| Interaction | COPE interactions | 1.95e-04 | 334 | 149 | 10 | int:COPE | |
| Interaction | NUMA1 interactions | KRT72 MYO1E WWP2 SMC3 GLYR1 SMARCA2 SMARCA4 MACF1 TNKS CTNNB1 HSP90AA1 HSP90AB1 | 1.96e-04 | 469 | 149 | 12 | int:NUMA1 |
| Interaction | TMOD1 interactions | 1.98e-04 | 161 | 149 | 7 | int:TMOD1 | |
| Interaction | CDC5L interactions | SYNE1 WWP2 SPTBN1 COPB2 PSMD1 RFC2 SMC3 PRPF3 SMARCA2 SMARCA4 MACF1 BICRAL KIF3C PRKDC ELL HSP90AA1 HSP90AB1 | 2.00e-04 | 855 | 149 | 17 | int:CDC5L |
| Interaction | PTPRN2 interactions | 2.07e-04 | 73 | 149 | 5 | int:PTPRN2 | |
| Interaction | ZFHX4 interactions | 2.07e-04 | 73 | 149 | 5 | int:ZFHX4 | |
| Interaction | CASP3 interactions | 2.09e-04 | 216 | 149 | 8 | int:CASP3 | |
| Interaction | HNF4A interactions | 2.13e-04 | 275 | 149 | 9 | int:HNF4A | |
| Interaction | TERF2 interactions | SYNE1 REV3L BLM BRCA2 SMC3 ZC3HAV1L MACF1 TNKS HSP90AB2P HSP90AA1 | 2.25e-04 | 340 | 149 | 10 | int:TERF2 |
| Interaction | HDAC2 interactions | SOX6 KRT17 WWP2 HIF1AN LETM1 PRDM1 SALL1 BRCA2 SMC3 CHD5 SMARCA2 SMARCA4 UTP20 PRKDC CTNNB1 HSP90AA1 HSP90AB1 | 2.30e-04 | 865 | 149 | 17 | int:HDAC2 |
| Interaction | KCTD13 interactions | KRT72 BIN1 MYO1E KRT19 SYNE1 SPTBN1 COPB2 KCNAB2 APC LETM1 MAPK8IP3 WDR47 CDKL5 ABLIM1 LRPPRC TENM4 SCN2A XRN1 SMARCA4 MACF1 CTNNB1 HSP90AA1 HSP90AB1 | 2.34e-04 | 1394 | 149 | 23 | int:KCTD13 |
| Interaction | NR5A2 interactions | 2.35e-04 | 41 | 149 | 4 | int:NR5A2 | |
| Interaction | APEX2 interactions | 2.35e-04 | 41 | 149 | 4 | int:APEX2 | |
| Interaction | EP300 interactions | SYNM COPB2 PSMD1 RFC2 DDB2 LETM1 ITIH3 STAT1 MAPK8IP3 CITED2 BRCA2 WDR11 SMC3 PRPF3 SMARCA2 SMARCA4 C3 TBXT PRKDC CTNNB1 EN1 ELL HSP90AA2P | 2.52e-04 | 1401 | 149 | 23 | int:EP300 |
| Interaction | MOS interactions | 2.83e-04 | 78 | 149 | 5 | int:MOS | |
| Interaction | DCLRE1C interactions | 2.83e-04 | 43 | 149 | 4 | int:DCLRE1C | |
| Interaction | LGALS3BP interactions | 2.84e-04 | 286 | 149 | 9 | int:LGALS3BP | |
| Interaction | NFIX interactions | 2.92e-04 | 227 | 149 | 8 | int:NFIX | |
| Interaction | SIK3 interactions | 3.00e-04 | 79 | 149 | 5 | int:SIK3 | |
| Interaction | FOXC1 interactions | 3.01e-04 | 228 | 149 | 8 | int:FOXC1 | |
| Interaction | C2CD4B interactions | 3.10e-04 | 44 | 149 | 4 | int:C2CD4B | |
| Interaction | PMS2 interactions | 3.18e-04 | 80 | 149 | 5 | int:PMS2 | |
| Interaction | DOT1L interactions | KRT19 RFC2 TRRAP STAT1 ZNF462 SMC3 PRPF3 GLYR1 A2ML1 SMARCA4 UTP20 TBXT PRKDC CTNNB1 ELL HSP90AA1 | 3.21e-04 | 807 | 149 | 16 | int:DOT1L |
| Interaction | NUDCD2 interactions | ZNF717 MYO1E SYNE1 SPTBN1 LAMA3 LRPPRC PXN PRKDC CCDC180 HSP90AA1 HSP90AB1 | 3.23e-04 | 424 | 149 | 11 | int:NUDCD2 |
| Interaction | PCNA interactions | WWP2 APC RFC2 TRRAP DDB2 HIF1AN LETM1 BRCA2 ASXL2 PRKDC CTNNB1 NOS1AP | 3.32e-04 | 497 | 149 | 12 | int:PCNA |
| Interaction | SLX4 interactions | REV3L MORC2 BLM ZNF462 SALL1 BRCA2 SMC3 PRPF3 SMARCA4 PRKDC ELL HSP90AA1 HSP90AB1 | 3.35e-04 | 572 | 149 | 13 | int:SLX4 |
| Interaction | IKBKB interactions | 3.48e-04 | 233 | 149 | 8 | int:IKBKB | |
| Interaction | KCNA6 interactions | 3.52e-04 | 19 | 149 | 3 | int:KCNA6 | |
| Interaction | TNNI3K interactions | 3.52e-04 | 19 | 149 | 3 | int:TNNI3K | |
| Interaction | PKNOX1 interactions | 3.57e-04 | 82 | 149 | 5 | int:PKNOX1 | |
| Interaction | CGNL1 interactions | 3.68e-04 | 46 | 149 | 4 | int:CGNL1 | |
| Interaction | H3C1 interactions | SYNE1 RFC2 MORC2 ZZEF1 TRRAP DDB2 BLM SMC3 PRPF3 GLYR1 SMARCA2 SMARCA4 PXN ZFHX3 PRKDC CTNNB1 DNAH8 | 3.68e-04 | 901 | 149 | 17 | int:H3C1 |
| Interaction | CCDC8 interactions | SNAP23 CUL9 PSMD1 RFC2 STAT1 ABLIM1 LRPPRC SMC3 GLYR1 MACF1 UTP20 PRKDC CTNNB1 HSP90AB1 | 3.72e-04 | 656 | 149 | 14 | int:CCDC8 |
| Interaction | IRF1 interactions | 3.77e-04 | 83 | 149 | 5 | int:IRF1 | |
| Interaction | HDAC5 interactions | COPB2 PSMD1 ITIH3 LRPPRC SMC3 SCP2 C3 PRKDC ELL HSP90AA1 HSP90AB1 | 3.78e-04 | 432 | 149 | 11 | int:HDAC5 |
| Interaction | HSP90AA1 interactions | KRT17 WWP2 SPTBN1 PSMD1 HEATR5A PRDM1 BLM LRPPRC BRCA2 ASB6 PLA2G4A C3 ASXL2 MAP3K15 PRKDC HSP90AB2P CTNNB1 HSP90AA1 HSP90AA4P HSP90AA2P HSP90AB1 | 4.06e-04 | 1263 | 149 | 21 | int:HSP90AA1 |
| Interaction | POU5F1 interactions | KRT19 WWP2 TRRAP ZNF462 SALL1 SMC3 PRPF3 CHD5 SMARCA2 SMARCA4 ZFHX3 PRKDC CTNNB1 | 4.07e-04 | 584 | 149 | 13 | int:POU5F1 |
| Interaction | SLC6A4 interactions | BIN1 KCNAB2 APC WDR47 CDKL5 CTNNA3 SCP2 MACF1 PNPLA8 CTNNB1 HSP90AB1 | 4.16e-04 | 437 | 149 | 11 | int:SLC6A4 |
| Interaction | PTGES3 interactions | MYLK CNOT10 DDB2 LRPPRC BRCA2 WDR11 PRKDC HSP90AB2P HSP90AA1 HSP90AA4P HSP90AB1 | 4.16e-04 | 437 | 149 | 11 | int:PTGES3 |
| Interaction | SIRT7 interactions | SPTBN1 COPB2 CUL9 PSMD1 TRRAP BLM LRPPRC GLYR1 XRN1 SMARCA2 SMARCA4 MACF1 UTP20 PRKDC ANKRD52 | 4.18e-04 | 744 | 149 | 15 | int:SIRT7 |
| Interaction | LHX2 interactions | 4.31e-04 | 183 | 149 | 7 | int:LHX2 | |
| Interaction | PTGS2 interactions | 4.34e-04 | 48 | 149 | 4 | int:PTGS2 | |
| Interaction | LATS1 interactions | DLG5 KRT17 WWP2 SPTBN1 RGPD1 APC GLYR1 HSP90AB2P ANKRD52 HSP90AA4P HSP90AB1 | 4.41e-04 | 440 | 149 | 11 | int:LATS1 |
| Interaction | ACTG1 interactions | DLG5 BIN1 WWP2 SPTBN1 ABLIM1 SMARCA2 SMARCA4 PNPLA8 ASXL2 CTNNB1 HSP90AA1 HSP90AB1 | 4.97e-04 | 520 | 149 | 12 | int:ACTG1 |
| Interaction | TLE3 interactions | 4.98e-04 | 376 | 149 | 10 | int:TLE3 | |
| Interaction | CENPA interactions | RFC2 MORC2 TRRAP BLM ZNF462 LRPPRC GLYR1 SMARCA2 UTP20 PRKDC | 5.09e-04 | 377 | 149 | 10 | int:CENPA |
| Interaction | RICTOR interactions | KRT17 MYO1E SPTBN1 RGPD1 APC STAT1 CDKL5 ABLIM1 LRPPRC ZC3HAV1L PRKDC HSP90AB2P HSP90AA1 HSP90AA2P HSP90AB1 | 5.14e-04 | 759 | 149 | 15 | int:RICTOR |
| Interaction | XRCC6 interactions | BIN1 SPTBN1 TRRAP DDB2 BLM LRPPRC BRCA2 PRPF3 GLYR1 SMARCA4 ZFHX3 TNKS ASXL2 PRKDC CTNNB1 QRSL1 HSP90AA1 | 5.15e-04 | 928 | 149 | 17 | int:XRCC6 |
| Interaction | DLG4 interactions | SESTD1 SYNE1 SPTBN1 KCNAB2 DCC CDKL5 ABLIM1 LRPPRC MACF1 CTNNB1 NOS1AP | 5.22e-04 | 449 | 149 | 11 | int:DLG4 |
| Interaction | HNF1B interactions | 5.39e-04 | 190 | 149 | 7 | int:HNF1B | |
| Interaction | UNC45B interactions | 5.50e-04 | 22 | 149 | 3 | int:UNC45B | |
| Interaction | TNIK interactions | 5.52e-04 | 381 | 149 | 10 | int:TNIK | |
| GeneFamily | Laminin subunits | 3.70e-05 | 12 | 102 | 3 | 626 | |
| GeneFamily | Heat shock 90kDa proteins | 3.12e-04 | 5 | 102 | 2 | 586 | |
| GeneFamily | Keratins, type I | 5.15e-04 | 28 | 102 | 3 | 608 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.11e-03 | 9 | 102 | 2 | 1234 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.11e-03 | 9 | 102 | 2 | 1203 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 1.38e-03 | 10 | 102 | 2 | 830 | |
| GeneFamily | CCR4-NOT transcription complex | 1.68e-03 | 11 | 102 | 2 | 1023 | |
| Coexpression | LIANG_SILENCED_BY_METHYLATION_UP | 1.20e-06 | 33 | 150 | 5 | M14553 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 2.31e-06 | 199 | 150 | 9 | M5893 | |
| Coexpression | SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 | KIF21B CDO1 LRRC32 LAMB3 MAPK8IP3 TBX19 SALL1 SMARCA2 C3 TAP2 LRRC23 NOS1AP | 6.06e-06 | 422 | 150 | 12 | M4308 |
| Coexpression | BROWNE_HCMV_INFECTION_18HR_DN | 1.05e-05 | 182 | 150 | 8 | M6641 | |
| Coexpression | KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP | 1.38e-05 | 136 | 150 | 7 | M126 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | MYLK FZD3 SPTBN1 CAPN3 SNAP23 NIPAL3 ABCA8 CITED2 CDKL5 ABLIM1 GSTK1 WDR11 RASA4 ZFHX3 BICRAL PSD4 | 1.66e-05 | 807 | 150 | 16 | M16651 |
| Coexpression | ONDER_CDH1_TARGETS_2_DN | KRT13 KRT17 MYO1E FZD3 LAMA3 LAMB3 GPR87 LAMC2 ABLIM1 PLA2G4A C3 IL1RAP | 1.89e-05 | 473 | 150 | 12 | M4306 |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP | 2.01e-05 | 199 | 150 | 8 | M4526 | |
| Coexpression | GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP | 2.01e-05 | 199 | 150 | 8 | M6314 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN | 2.57e-05 | 206 | 150 | 8 | M14134 | |
| Coexpression | PUJANA_BREAST_CANCER_LIT_INT_NETWORK | 2.57e-05 | 101 | 150 | 6 | M15356 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_DN | CDO1 SPTBN1 ABLIM1 CELF2 RASA4 COQ9 SMARCA2 SCP2 TXNDC16 RASA4B EN1 | 3.26e-05 | 421 | 150 | 11 | MM985 |
| Coexpression | LI_PROSTATE_CANCER_EPIGENETIC | 3.27e-05 | 32 | 150 | 4 | M10861 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | APC REV3L ZZEF1 TRRAP BLM LRPPRC ATP11B BRCA2 SMC3 SMARCA2 MACF1 UTP20 ZFHX3 TNKS BICRAL IL1RAP | 3.38e-05 | 856 | 150 | 16 | M4500 |
| Coexpression | OSMAN_BLADDER_CANCER_DN | SCFD2 COPB2 HIF1AN CELF2 PRPF3 SMARCA2 TNKS BICRAL ASXL2 QRSL1 ELL | 4.03e-05 | 431 | 150 | 11 | M16858 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA2 | SOX6 KIF21B KRT17 REV3L DCC RASA4 CHD5 SCN2A SCN8A ZFHX3 BICRAL EN1 | 4.17e-05 | 513 | 150 | 12 | M39069 |
| Coexpression | MURARO_PANCREAS_ENDOTHELIAL_CELL | 4.71e-05 | 362 | 150 | 10 | M39176 | |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_DN | 4.77e-05 | 165 | 150 | 7 | M8121 | |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN | BIN1 KRT17 MYO1E SPTBN1 LAMA3 LAMB3 LAMC2 PLA2G4A C3 IL1RAP TAP2 | 6.81e-05 | 457 | 150 | 11 | M14507 |
| Coexpression | JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP | MYLK KRT17 SPTBN1 CUL9 CITED2 ATP11B ANGPTL4 MACF1 CTNNB1 HSP90AA1 | 7.38e-05 | 382 | 150 | 10 | M38972 |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_DN | CDO1 SPTBN1 ABLIM1 CELF2 RASA4 COQ9 SMARCA2 SCP2 TXNDC16 EN1 | 1.03e-04 | 398 | 150 | 10 | M7514 |
| Coexpression | PARENT_MTOR_SIGNALING_UP | CDO1 BIN1 SYNE1 CUL9 LAMB3 STAT1 CITED2 DHRS12 HEATR6 SMARCA2 CTNNB1 PSD4 | 1.08e-04 | 567 | 150 | 12 | M16909 |
| Coexpression | GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_3H_UP | 1.08e-04 | 188 | 150 | 7 | M6167 | |
| Coexpression | POOLA_INVASIVE_BREAST_CANCER_DN | 1.20e-04 | 133 | 150 | 6 | M6767 | |
| Coexpression | ZHONG_PFC_C3_MICROGLIA | KIF21B KRT19 FZD3 SPTBN1 WDR47 ABLIM1 TENM4 SGSM2 SCN2A SMARCA2 KIF3C | 1.22e-04 | 488 | 150 | 11 | M39104 |
| Coexpression | GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_DN | 1.45e-04 | 197 | 150 | 7 | M9580 | |
| Coexpression | GSE18281_CORTICAL_VS_MEDULLARY_THYMOCYTE_UP | 1.54e-04 | 199 | 150 | 7 | M7252 | |
| Coexpression | GSE27786_LSK_VS_LIN_NEG_CELL_UP | 1.59e-04 | 200 | 150 | 7 | M4739 | |
| Coexpression | GSE21360_PRIMARY_VS_TERTIARY_MEMORY_CD8_TCELL_DN | 1.59e-04 | 200 | 150 | 7 | M7642 | |
| Coexpression | GSE360_DC_VS_MAC_UP | 1.59e-04 | 200 | 150 | 7 | M5172 | |
| Coexpression | GSE39152_BRAIN_VS_SPLEEN_CD103_NEG_MEMORY_CD8_TCELL_UP | 1.59e-04 | 200 | 150 | 7 | M9075 | |
| Coexpression | BURTON_ADIPOGENESIS_9 | 1.62e-04 | 89 | 150 | 5 | MM1026 | |
| Coexpression | ELVIDGE_HIF1A_TARGETS_DN | 1.80e-04 | 91 | 150 | 5 | M2513 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN | 1.89e-04 | 92 | 150 | 5 | M3672 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 1.95e-04 | 20 | 150 | 3 | MM17053 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | KIF21B APC LAMA3 LAMC2 REV3L DCC CCDC141 CITED2 ZNF462 CELF2 RASA4 CHD5 SCN2A SCN8A ZFHX3 TNKS KIF3C | 2.07e-04 | 1106 | 150 | 17 | M39071 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | KIF21B REV3L STAR ZNF462 CDKL5 TENM4 CELF2 RASA4 CHD5 SCN2A SCN8A CTNNA3 ZFHX3 | 2.11e-04 | 703 | 150 | 13 | M39070 |
| Coexpression | DELYS_THYROID_CANCER_UP | 2.54e-04 | 445 | 150 | 10 | M3645 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#3_top-relative-expression-ranked_200 | 1.81e-05 | 8 | 148 | 3 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k3_200 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#3_top-relative-expression-ranked_500 | 4.07e-05 | 28 | 148 | 4 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k3_500 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.81e-05 | 57 | 148 | 5 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | SOX6 KRT13 FZD3 REV3L DCC LRRC8D LETM1 WDR47 BLM AIFM2 SALL1 CELF2 BRCA2 SMC3 SMARCA4 UTP20 PRKDC HSP90AA1 HSP90AB1 | 5.97e-05 | 989 | 148 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchioEpithel_top-relative-expression-ranked_100 | 6.43e-05 | 98 | 148 | 6 | PCBC_ctl_BronchioEpithel_100 | |
| ToppCell | P28-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.07e-07 | 168 | 150 | 8 | 8c8dbdbc7053f34e4ca0c5067af502fbea109fc1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-07 | 178 | 150 | 8 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.44e-07 | 187 | 150 | 8 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | ASK440-Epithelial-Type_1|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.62e-07 | 197 | 150 | 8 | 1eda2c2504451a3d626dda5c2b2b12eeaa6bca54 | |
| ToppCell | ASK440-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.62e-07 | 197 | 150 | 8 | 782449c522c9e16e72bf999a73090688a3aefe06 | |
| ToppCell | ASK428-Epithelial-Type_1|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.62e-07 | 197 | 150 | 8 | 9ae6661c307791c3f0ecd3d378e3d917565e5498 | |
| ToppCell | distal-1-Epithelial-Basal|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.62e-07 | 197 | 150 | 8 | 25a2ccc98b973611de0d920b1b455d0b40f0d37f | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor|Control_saline / Treatment groups by lineage, cell group, cell type | 3.76e-07 | 198 | 150 | 8 | 030ef63e2fc5b3d601c1a48462d797aa19ee7ff5 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.91e-07 | 199 | 150 | 8 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | mild-CD4+_Tcm|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.91e-07 | 199 | 150 | 8 | 06c8a0e39f7a33736548f04a5e2263334c8541cf | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.91e-07 | 199 | 150 | 8 | 60919c2af31d39a2d36d7bc432e43dab2a4e05fb | |
| ToppCell | LPS_anti-TNF-Epithelial_airway|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.91e-07 | 199 | 150 | 8 | 6aca164bbbb961f34b1e6f1857f91ade5c059405 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.06e-07 | 200 | 150 | 8 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Basal|Biopsy_Other_PF / Sample group, Lineage and Cell type | 4.06e-07 | 200 | 150 | 8 | 7098ae4b0ea8ba607519eaed8577c577530fc2a1 | |
| ToppCell | AT1_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.04e-06 | 173 | 150 | 7 | 3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e | |
| ToppCell | AT1_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 2.04e-06 | 173 | 150 | 7 | b29816427428c7053017477f59b828bf1357f3b2 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.12e-06 | 174 | 150 | 7 | d0e3d15731de6c19c232e3aa492c39d8151cf4ed | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.37e-06 | 177 | 150 | 7 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | COVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.56e-06 | 179 | 150 | 7 | 754f69bac7a1d5137f5141f6193285ccbfe361cb | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.56e-06 | 179 | 150 | 7 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 2.96e-06 | 183 | 150 | 7 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.96e-06 | 183 | 150 | 7 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.18e-06 | 185 | 150 | 7 | fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 3.41e-06 | 187 | 150 | 7 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-06 | 189 | 150 | 7 | 324c81285c51f4f8bb1aef428b18fe2c549c2c11 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-06 | 190 | 150 | 7 | 00fd993675faf53adf985b9316a18c8a33242029 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.79e-06 | 190 | 150 | 7 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-06 | 190 | 150 | 7 | 8cda09d761c6b504a744959d587c183f94f1beeb | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.92e-06 | 191 | 150 | 7 | 094c9d3270fc1e487ccf10fb4936af5f081f6009 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.92e-06 | 191 | 150 | 7 | 80484d39f34703a33b9bac09826b7a526e883cab | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.92e-06 | 191 | 150 | 7 | 5c4e4e9de14edfae072a2a2882220a31bebf51b2 | |
| ToppCell | AT1_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.06e-06 | 192 | 150 | 7 | 0444f9e9cef7403e220e862b5a787443d3f5c9ac | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-06 | 193 | 150 | 7 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-06 | 193 | 150 | 7 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-06 | 193 | 150 | 7 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | AT1_cells|World / lung cells shred on cell class, cell subclass, sample id | 4.50e-06 | 195 | 150 | 7 | 792d6a49b0a875a00569071183d195287a9925c5 | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.50e-06 | 195 | 150 | 7 | 7e0ef92059ff34e368d2324815f49b50e3ca7332 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.50e-06 | 195 | 150 | 7 | b072fdc2131173f562e55dd78226eaf2c57d3690 | |
| ToppCell | AT1|World / shred by cell class for parenchyma | 4.65e-06 | 196 | 150 | 7 | 2bc487f8a109a6961ebff111dec79c2227ea60ac | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.65e-06 | 196 | 150 | 7 | 6731fef8c148b6681d6ed38afdf23c8213e0bbbe | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.65e-06 | 196 | 150 | 7 | 6856317cd0cdcb88fe54b4ae905d91e13495b1c4 | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.81e-06 | 197 | 150 | 7 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.81e-06 | 197 | 150 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.81e-06 | 197 | 150 | 7 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2|Control_saline / Treatment groups by lineage, cell group, cell type | 4.81e-06 | 197 | 150 | 7 | b8f62fcd6eb8f47b3cc41f616126f82c68a36e87 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.81e-06 | 197 | 150 | 7 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 4.81e-06 | 197 | 150 | 7 | f870a26f322668781e3d2832c5d9ef2c7c91011f | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.97e-06 | 198 | 150 | 7 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Airway-Club|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.97e-06 | 198 | 150 | 7 | 6712216c5a7fd86b68fd45b0ff7794975f19774e | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.97e-06 | 198 | 150 | 7 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Squamous|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.97e-06 | 198 | 150 | 7 | b7495369baba203490c067a58fc8456a778a12e4 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.97e-06 | 198 | 150 | 7 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | ASK428-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.97e-06 | 198 | 150 | 7 | 0047a9ef7684230ac5179efea94461480e90bdaf | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.14e-06 | 199 | 150 | 7 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.14e-06 | 199 | 150 | 7 | 667e1a56c33a2681af8dc1b7dbc3a9858e2c3c05 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 5.14e-06 | 199 | 150 | 7 | 0447f8f53389fe7c6ddc04a97d86e74122ea16f4 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.14e-06 | 199 | 150 | 7 | 2dae9db4d25f1a390134da2b6621564b274fe910 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.14e-06 | 199 | 150 | 7 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 5.14e-06 | 199 | 150 | 7 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.31e-06 | 200 | 150 | 7 | afac850d5a40de0d6f02857cf81a19443d90b1eb | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.31e-06 | 200 | 150 | 7 | cf191104484bfb2b9f87de416b9453135f8833c1 | |
| ToppCell | LPS_IL1RA-Epithelial_airway|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.31e-06 | 200 | 150 | 7 | a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.31e-06 | 200 | 150 | 7 | 1c02a7f4047d1d2208cc522c6bb4a4989d7845bb | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.31e-06 | 200 | 150 | 7 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Basal_1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 5.31e-06 | 200 | 150 | 7 | 592c7c3ded409a9957cbcdc62fcc213fa8eae598 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.31e-06 | 200 | 150 | 7 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.31e-06 | 200 | 150 | 7 | 8cfbde43c5e66269ad128aa5398b1517667d7d36 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.31e-06 | 200 | 150 | 7 | 03051d2190244208905e1611019d4b8fd200bae0 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.31e-06 | 200 | 150 | 7 | 0594ca7bc313b73e1dc800cf058f8f798b0284cb | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.31e-06 | 200 | 150 | 7 | 61811380d9252f12f27b7ad4752380b52692677f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.07e-06 | 140 | 150 | 6 | 2c44e8cc5190226049be7ebc465d685393e701c4 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 154 | 150 | 6 | a5289000597068ee8d559f89bce7bce31f35dd57 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-05 | 154 | 150 | 6 | 9200e2f1783e54cbc5dfc3b485b57c761af74a46 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-05 | 162 | 150 | 6 | 9dca585c734faea0e1122c70f5dc36cef3dbd2c6 | |
| ToppCell | droplet-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 163 | 150 | 6 | a794540f2d8984f963c08f05175e4bc916fcc224 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 2.05e-05 | 165 | 150 | 6 | 9795ce31689bc63f5a2d68725ef00b23a90c3846 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-05 | 166 | 150 | 6 | 11b0ae82b3068ef91715dbdd49fe8e9791b4a480 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-05 | 166 | 150 | 6 | fcc1aec31ebd39432d4cb284dc8fadf34e3c566a | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.27e-05 | 168 | 150 | 6 | f150beee37e0252951a88adcd9e3f0a22e5cfdd9 | |
| ToppCell | AT1-AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.35e-05 | 169 | 150 | 6 | 815474855a70498a74e52f6583113c63b7267a0c | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.59e-05 | 172 | 150 | 6 | e9095c3dac66cf93d31f5f88364b565abacb1e2d | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.77e-05 | 174 | 150 | 6 | 3c47d069bd836599a8d40eae485c23d4d3487517 | |
| ToppCell | AT1_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 2.95e-05 | 176 | 150 | 6 | 4a30bb771297b30926fb98e2b5ec0dbdc46feac7 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.15e-05 | 178 | 150 | 6 | 9a3ef66814dfca7b37024e7f79e86ea8c72ae10f | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.15e-05 | 178 | 150 | 6 | b413a634283550fa224db7d0d05956e3f64694a1 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.15e-05 | 178 | 150 | 6 | 49a2271718637522f74334068d252963ee13b1ce | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.15e-05 | 178 | 150 | 6 | 1817bc520f3d23da8c0fa09bba50ae703a820cb1 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.15e-05 | 178 | 150 | 6 | 19b5432aa1d7f616d58a106543c18cf2d7ca840c | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 3.25e-05 | 179 | 150 | 6 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.25e-05 | 179 | 150 | 6 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.25e-05 | 179 | 150 | 6 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.25e-05 | 179 | 150 | 6 | d5763912a4ce7188535675e338799b856edb9dda | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.25e-05 | 179 | 150 | 6 | b559f5a72cc9e3e35d05cb539b5c2e006e56e652 | |
| ToppCell | AT1_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 3.35e-05 | 180 | 150 | 6 | 2d52cb5f77dde0e3dccac1333d4ec67ec680fcb2 | |
| ToppCell | AT1_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 3.35e-05 | 180 | 150 | 6 | e1964002681f80d8d62406b6ee52a01e1829ccf2 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.56e-05 | 182 | 150 | 6 | a95956ce4adccb34cc0c47ebfa1878ce4617904e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.56e-05 | 182 | 150 | 6 | 17ed11a7ea366dd3106400511d5e628d3f1a9c3e | |
| ToppCell | (7)_Epithelial-H_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.79e-05 | 184 | 150 | 6 | 1f76b37c265b519171b767a52d48f31f0cdc4a3c | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.79e-05 | 184 | 150 | 6 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.79e-05 | 184 | 150 | 6 | 7cc5796557379c3d1db078c1aeda40659c6e401c | |
| Computational | Neighborhood of CDH3 | 1.17e-07 | 27 | 97 | 6 | GNF2_CDH3 | |
| Computational | Neighborhood of SERPINB5 | 1.48e-07 | 28 | 97 | 6 | GNF2_SERPINB5 | |
| Computational | Intermediate filaments and keratins. | 7.27e-06 | 80 | 97 | 7 | MODULE_357 | |
| Computational | Genes in the cancer module 153. | 1.22e-05 | 34 | 97 | 5 | MODULE_153 | |
| Computational | Genes in the cancer module 297. | 8.11e-05 | 80 | 97 | 6 | MODULE_297 | |
| Computational | Intermediate filaments and MT. | 3.59e-04 | 68 | 97 | 5 | MODULE_438 | |
| Computational | Intermediate filaments. | 5.65e-04 | 75 | 97 | 5 | MODULE_154 | |
| Computational | Genes in the cancer module 533. | 6.99e-04 | 45 | 97 | 4 | MODULE_533 | |
| Drug | Dieldrin | SCFD2 SOX6 DLG5 BIN1 STBD1 MYLK FZD3 WWP2 CAPN3 COMMD5 SNAP23 PSMD1 NIPAL3 STAR AIFM2 HEATR6 SALL1 BRCA2 ASB6 SCN2A SMARCA4 TXNDC16 QRSL1 | 3.44e-06 | 1217 | 147 | 23 | ctd:D004026 |
| Drug | AC1L1DW2 | MYLK SPTBN1 SNAP23 PSMD1 AIFM2 CTNNB1 HSP90AA1 HSP90AA2P HSP90AB1 | 3.49e-06 | 186 | 147 | 9 | CID000002532 |
| Drug | 1-methyl-2-nitro-1-nitrosoguanidine | 3.51e-06 | 238 | 147 | 10 | CID000006261 | |
| Drug | methyl methanesulfonate | SYNM REV3L MAGEE1 RFC2 DDB2 BLM BRCA2 SMARCA2 SMARCA4 TBXT TNKS PRKDC | 4.51e-06 | 364 | 147 | 12 | CID000004156 |
| Drug | 16, 16-dimethylprostaglandin E2 methyl acetate solution; Down 200; 10uM; PC3; HT_HG-U133A | 5.35e-06 | 196 | 147 | 9 | 6562_DN | |
| Drug | Cefotaxime sodium salt [64485-93-4]; Down 200; 8.4uM; PC3; HT_HG-U133A | 5.57e-06 | 197 | 147 | 9 | 2072_DN | |
| Drug | NSC330499 | 9.06e-06 | 7 | 147 | 3 | CID000433447 | |
| Drug | UCS15A | 9.17e-06 | 21 | 147 | 4 | CID005311041 | |
| Drug | ICI 182,780 | SYNE1 COPB2 STAR STAT1 C3 PRKDC CTNNB1 HSP90AA1 HSP90AA2P HSP90AB1 | 1.13e-05 | 272 | 147 | 10 | CID000104741 |
| Drug | S2A | 1.34e-05 | 23 | 147 | 4 | CID016058643 | |
| Drug | dihydropyran | 1.44e-05 | 8 | 147 | 3 | CID000008080 | |
| Drug | phenyldichloroarsine | 1.44e-05 | 8 | 147 | 3 | CID000012762 | |
| Drug | 5,8-quinolinedione | 2.15e-05 | 9 | 147 | 3 | CID000388306 | |
| Drug | nickel chloride | DLG5 STBD1 SYNE1 WWP2 COMMD5 APC PSMD1 LAMC2 SCLY HIF1AN ITIH3 STAT1 GSTA3 CITED2 AIFM2 SMC3 CHD5 SCN2A ANGPTL4 C3 PRKDC | 2.30e-05 | 1178 | 147 | 21 | ctd:C022838 |
| Drug | sebacate | 2.38e-05 | 181 | 147 | 8 | CID000005192 | |
| Drug | Hydrocotarnine hydrobromide [5985-00-2]; Down 200; 13.2uM; HL60; HG-U133A | 2.68e-05 | 184 | 147 | 8 | 1772_DN | |
| Drug | mitomycin C | 2.78e-05 | 241 | 147 | 9 | CID000005746 | |
| Drug | scriptaid; Down 200; 10uM; PC3; HT_HG-U133A | 3.63e-05 | 192 | 147 | 8 | 6919_DN | |
| Drug | Glycocholic acid [475-31-0]; Down 200; 8.6uM; PC3; HT_HG-U133A | 3.76e-05 | 193 | 147 | 8 | 6716_DN | |
| Drug | hydrazine | 3.76e-05 | 193 | 147 | 8 | ctd:C029424 | |
| Drug | Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 3.76e-05 | 193 | 147 | 8 | 3866_DN | |
| Drug | butyrate | KRT72 KRT13 KRT17 KRT19 APC LAMA3 LAMC2 REV3L STAT1 GSTA3 PRDM1 FAH GSTK1 CTNNB1 QRSL1 NOS1AP | 3.78e-05 | 767 | 147 | 16 | CID000000264 |
| Drug | Tocainide hydrochloride; Up 200; 17.4uM; MCF7; HT_HG-U133A | 3.90e-05 | 194 | 147 | 8 | 4838_UP | |
| Drug | Meclozine dihydrochloride [1104-22-9]; Down 200; 8.6uM; PC3; HT_HG-U133A | 4.05e-05 | 195 | 147 | 8 | 4646_DN | |
| Drug | 3-amino-5-chlorobenzoic acid | 4.14e-05 | 2 | 147 | 2 | CID010986726 | |
| Drug | monocillin III | 4.14e-05 | 2 | 147 | 2 | CID006478910 | |
| Drug | pochonin A | 4.14e-05 | 2 | 147 | 2 | CID006478909 | |
| Drug | PU-H71 | 4.14e-05 | 2 | 147 | 2 | CID009549213 | |
| Drug | 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine | 4.14e-05 | 2 | 147 | 2 | DB02754 | |
| Drug | 1uyc | 4.14e-05 | 2 | 147 | 2 | CID000448969 | |
| Drug | PU-9 | 4.14e-05 | 2 | 147 | 2 | CID000448971 | |
| Drug | P u 0 | 4.14e-05 | 2 | 147 | 2 | CID000448974 | |
| Drug | 2qf6 | 4.14e-05 | 2 | 147 | 2 | CID013373715 | |
| Drug | Geldanamycin | 4.14e-05 | 2 | 147 | 2 | DB02424 | |
| Drug | CHEBI:42139 | 4.14e-05 | 2 | 147 | 2 | CID011562562 | |
| Drug | 2qfo | 4.14e-05 | 2 | 147 | 2 | CID000600769 | |
| Drug | 3eko | 4.14e-05 | 2 | 147 | 2 | CID011160307 | |
| Drug | 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE | 4.14e-05 | 2 | 147 | 2 | DB07877 | |
| Drug | 1uyi | 4.14e-05 | 2 | 147 | 2 | CID005289232 | |
| Drug | 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL | 4.14e-05 | 2 | 147 | 2 | DB07594 | |
| Drug | NSC683666 | 4.14e-05 | 2 | 147 | 2 | CID005469153 | |
| Drug | H 64 | 4.14e-05 | 2 | 147 | 2 | CID006914564 | |
| Drug | SureCN4151355 | 4.14e-05 | 2 | 147 | 2 | CID015942101 | |
| Drug | Pu-3 | 4.19e-05 | 11 | 147 | 3 | CID000448965 | |
| Drug | I-hu | 4.19e-05 | 11 | 147 | 3 | CID009547901 | |
| Drug | AC1L1OB7 | 4.19e-05 | 11 | 147 | 3 | CID000007235 | |
| Drug | Bemegride [64-65-3]; Down 200; 25.8uM; MCF7; HT_HG-U133A | 4.20e-05 | 196 | 147 | 8 | 3389_DN | |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 4.20e-05 | 196 | 147 | 8 | 5307_UP | |
| Drug | CP-944629 [668990-94-1]; Up 200; 10uM; PC3; HT_HG-U133A | 4.20e-05 | 196 | 147 | 8 | 7502_UP | |
| Drug | Pregnenolone [145-13-1]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 4.20e-05 | 196 | 147 | 8 | 4802_DN | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; MCF7; HT_HG-U133A | 4.35e-05 | 197 | 147 | 8 | 3870_DN | |
| Drug | Dimenhydrinate [523-87-5]; Up 200; 8.6uM; HL60; HT_HG-U133A | 4.51e-05 | 198 | 147 | 8 | 2400_UP | |
| Drug | (1)-Nipecotic acid [498-95-3]; Down 200; 31uM; MCF7; HT_HG-U133A | 4.51e-05 | 198 | 147 | 8 | 6500_DN | |
| Drug | Clonidine hydrochloride [4205-91-8]; Up 200; 15uM; MCF7; HT_HG-U133A | 4.51e-05 | 198 | 147 | 8 | 3172_UP | |
| Drug | Pirenperone [ 75444-65-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 4.51e-05 | 198 | 147 | 8 | 5639_UP | |
| Drug | Chloroquine diphosphate [50-63-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 4.51e-05 | 198 | 147 | 8 | 7012_UP | |
| Drug | Ticlopidine hydrochloride [53885-35-1]; Down 200; 13.4uM; PC3; HT_HG-U133A | 4.51e-05 | 198 | 147 | 8 | 4074_DN | |
| Drug | Amiloride hydrochloride dihydrate [17440-83-4]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 4.67e-05 | 199 | 147 | 8 | 1470_UP | |
| Drug | Androsterone [53-41-8]; Down 200; 13.8uM; PC3; HT_HG-U133A | 4.67e-05 | 199 | 147 | 8 | 4635_DN | |
| Drug | 2ohu | 5.56e-05 | 12 | 147 | 3 | CID011633167 | |
| Drug | AC1NDT8D | 6.65e-05 | 34 | 147 | 4 | CID004631220 | |
| Drug | FLT3 inhibitor | 9.11e-05 | 14 | 147 | 3 | CID001048845 | |
| Drug | FG 1 | 9.11e-05 | 14 | 147 | 3 | CID005288213 | |
| Drug | alachlor | 9.68e-05 | 71 | 147 | 5 | CID000002078 | |
| Drug | al-Badry | 1.01e-04 | 165 | 147 | 7 | CID000004545 | |
| Drug | laulimalide | 1.04e-04 | 38 | 147 | 4 | CID006918457 | |
| Drug | sulforhodamine B | 1.11e-04 | 73 | 147 | 5 | CID000065191 | |
| Drug | AC1L9PMA | 1.13e-04 | 15 | 147 | 3 | CID000451405 | |
| Drug | Smoke | BIN1 KRT13 KRT19 SPTBN1 GPR87 SCLY ABCA8 STAT1 ZNF462 ABLIM1 GSTK1 ANGPTL4 PLA2G4A CTNNB1 SERPINA5 HSP90AA1 NOS1AP | 1.19e-04 | 937 | 147 | 17 | ctd:D012906 |
| Drug | pochonin D | 1.24e-04 | 3 | 147 | 2 | CID006478913 | |
| Drug | azaquinone | 1.24e-04 | 3 | 147 | 2 | CID000099132 | |
| Drug | d 1 v | 1.24e-04 | 3 | 147 | 2 | CID000683940 | |
| Drug | AC1MD0RC | 1.24e-04 | 3 | 147 | 2 | CID002829073 | |
| Drug | 4-phenylthiosemicarbazide | 1.24e-04 | 3 | 147 | 2 | CID000730679 | |
| Drug | HM-9 | 1.24e-04 | 3 | 147 | 2 | CID000433437 | |
| Drug | Glyoxylspermidine | 1.24e-04 | 3 | 147 | 2 | CID000133564 | |
| Drug | Velcade (bortezomib | KRT72 KRT13 KRT17 KRT19 PSMD1 HIF1AN TNKS HSP90AA1 HSP90AA2P HSP90AB1 | 1.64e-04 | 374 | 147 | 10 | CID000093860 |
| Drug | geldanamycin; Up 200; 1uM; HL60; HT_HG-U133A | 1.67e-04 | 179 | 147 | 7 | 1169_UP | |
| Drug | AC1NRBRB | 1.69e-04 | 43 | 147 | 4 | CID005288597 | |
| Drug | Etoposide [33419-42-0]; Up 200; 6.8uM; MCF7; HT_HG-U133A | 1.91e-04 | 183 | 147 | 7 | 5027_UP | |
| Drug | Vitallium | 1.92e-04 | 244 | 147 | 8 | ctd:D014800 | |
| Drug | mangostin | 2.00e-04 | 18 | 147 | 3 | CID005281650 | |
| Drug | sulfur mustard | 2.02e-04 | 130 | 147 | 6 | CID000010461 | |
| Drug | Toxins, Biological | KRT13 KRT17 KRT19 LAMA3 LAMC2 DCC STAT1 PLA2G4A C3 KIF3C CTNNB1 TAP2 HSP90AB1 | 2.39e-04 | 632 | 147 | 13 | ctd:D014118 |
| Drug | 1,2-dimethylhydrazine | 2.40e-04 | 86 | 147 | 5 | CID000001322 | |
| Drug | cephadroxil | 2.40e-04 | 86 | 147 | 5 | CID000002610 | |
| Drug | 11-deoxy-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 2.40e-04 | 190 | 147 | 7 | 7519_UP | |
| Drug | Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 2.40e-04 | 190 | 147 | 7 | 3833_DN | |
| Drug | APETx2 protein, Anthopleura elegantissima | 2.46e-04 | 4 | 147 | 2 | ctd:C501880 | |
| Drug | N-(5-methylisoxazol-3-yl)-2-(4-(thiophen-2-yl)-6-(trifluoromethyl)pyrimidin-2-ylthio)acetamide | 2.46e-04 | 4 | 147 | 2 | ctd:C576667 | |
| Drug | uranyl chloride | 2.46e-04 | 4 | 147 | 2 | CID000082259 | |
| Drug | methoxyhydroquinone | 2.46e-04 | 4 | 147 | 2 | CID000069988 | |
| Drug | 11p110 | 2.46e-04 | 4 | 147 | 2 | CID002382787 | |
| Drug | DAPM | 2.48e-04 | 135 | 147 | 6 | CID000007577 | |
| Drug | CP-319743 [172078-87-4]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.48e-04 | 191 | 147 | 7 | 7486_UP | |
| Drug | 17-DMAG; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.48e-04 | 191 | 147 | 7 | 6933_UP | |
| Drug | Pipemidic acid [51940-44-4]; Down 200; 13.2uM; PC3; HT_HG-U133A | 2.56e-04 | 192 | 147 | 7 | 6752_DN | |
| Drug | Metixene hydrochloride [1553-34-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.56e-04 | 192 | 147 | 7 | 3313_UP | |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 2.56e-04 | 192 | 147 | 7 | 4175_UP | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 2.56e-04 | 192 | 147 | 7 | 4104_DN | |
| Disease | cancer (implicated_via_orthology) | PIGZ BRCA2 SMARCA2 SMARCA4 MACF1 HSP90AB2P CTNNB1 HSP90AA1 HSP90AA4P HSP90AA2P HSP90AB1 | 9.10e-08 | 268 | 144 | 11 | DOID:162 (implicated_via_orthology) |
| Disease | Junctional epidermolysis bullosa | 1.14e-07 | 3 | 144 | 3 | cv:C0079301 | |
| Disease | Junctional epidermolysis bullosa gravis of Herlitz | 1.14e-07 | 3 | 144 | 3 | cv:C0079683 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE | 1.14e-07 | 3 | 144 | 3 | 226700 | |
| Disease | Herlitz Disease | 4.54e-07 | 4 | 144 | 3 | C0079683 | |
| Disease | Epidermolysis Bullosa Progressiva | 4.54e-07 | 4 | 144 | 3 | C0079297 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 6.68e-07 | 101 | 144 | 7 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | Adult junctional epidermolysis bullosa (disorder) | 1.13e-06 | 5 | 144 | 3 | C0268374 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder) | 1.13e-06 | 5 | 144 | 3 | C2608084 | |
| Disease | junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology) | 1.13e-06 | 5 | 144 | 3 | DOID:0060738 (implicated_via_orthology) | |
| Disease | neuroimaging measurement | SCFD2 ZNF438 KIF21B KRT17 FZD3 SPTBN1 RGPD1 APC PSMD1 REV3L DCC HIF1AN STAT1 MAPK8IP3 ZNF462 ABLIM1 PRPF3 SMARCA2 MACF1 | 1.20e-06 | 1069 | 144 | 19 | EFO_0004346 |
| Disease | Junctional Epidermolysis Bullosa | 2.25e-06 | 6 | 144 | 3 | C0079301 | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 3.93e-06 | 7 | 144 | 3 | DOID:3209 (is_implicated_in) | |
| Disease | coenzyme Q10 deficiency disease (implicated_via_orthology) | 3.93e-06 | 7 | 144 | 3 | DOID:0050730 (implicated_via_orthology) | |
| Disease | breast cancer (implicated_via_orthology) | 6.35e-06 | 25 | 144 | 4 | DOID:1612 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 6.54e-06 | 93 | 144 | 6 | C1535926 | |
| Disease | Adenocarcinoma of large intestine | 7.86e-06 | 96 | 144 | 6 | C1319315 | |
| Disease | medulloblastoma (is_implicated_in) | 1.33e-05 | 10 | 144 | 3 | DOID:0050902 (is_implicated_in) | |
| Disease | smoking behaviour measurement | 1.42e-05 | 222 | 144 | 8 | EFO_0005671 | |
| Disease | brain measurement, neuroimaging measurement | ZNF438 KIF21B SPTBN1 RGPD1 LAMC2 DCC HIF1AN ZNF462 PRPF3 SMARCA2 MACF1 ZFHX3 | 1.74e-05 | 550 | 144 | 12 | EFO_0004346, EFO_0004464 |
| Disease | nephrotic syndrome type 9 (implicated_via_orthology) | 2.37e-05 | 2 | 144 | 2 | DOID:0080391 (implicated_via_orthology) | |
| Disease | primary coenzyme Q10 deficiency 4 (implicated_via_orthology) | 2.37e-05 | 2 | 144 | 2 | DOID:0070241 (implicated_via_orthology) | |
| Disease | colon adenocarcinoma (implicated_via_orthology) | 2.37e-05 | 2 | 144 | 2 | DOID:234 (implicated_via_orthology) | |
| Disease | hepatoblastoma (is_marker_for) | 4.96e-05 | 15 | 144 | 3 | DOID:687 (is_marker_for) | |
| Disease | COENZYME Q10 DEFICIENCY | 7.07e-05 | 3 | 144 | 2 | C1843920 | |
| Disease | Benign familial infantile epilepsy | 7.07e-05 | 3 | 144 | 2 | cv:C5575231 | |
| Disease | Aberrant Crypt Foci | 7.07e-05 | 3 | 144 | 2 | C1879526 | |
| Disease | junctional epidermolysis bullosa Herlitz type (implicated_via_orthology) | 7.07e-05 | 3 | 144 | 2 | DOID:0060737 (implicated_via_orthology) | |
| Disease | COENZYME Q10 DEFICIENCY, PRIMARY, 1 | 7.07e-05 | 3 | 144 | 2 | C3551954 | |
| Disease | Fibromatosis, Aggressive | 7.07e-05 | 3 | 144 | 2 | C0079218 | |
| Disease | Schizophrenia | FZD3 APC DCC TRRAP ITIH3 TENM4 CELF2 WDR11 SMARCA2 PLA2G4A CTNNB1 EN1 TAP2 NOS1AP | 1.13e-04 | 883 | 144 | 14 | C0036341 |
| Disease | osteosarcoma (implicated_via_orthology) | 1.41e-04 | 4 | 144 | 2 | DOID:3347 (implicated_via_orthology) | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | REV3L DCC DDB2 LRPPRC TENM4 CELF2 SGSM2 SCN2A CTNNA3 ZFHX3 BICRAL PRKDC ELL | 1.59e-04 | 801 | 144 | 13 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | Neoplasm of the genitourinary tract | 2.14e-04 | 24 | 144 | 3 | cv:C0042065 | |
| Disease | Cerebellar Ataxia | 2.34e-04 | 5 | 144 | 2 | C0007758 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 2.34e-04 | 5 | 144 | 2 | C3281201 | |
| Disease | Drug habituation | 2.58e-04 | 115 | 144 | 5 | C0013170 | |
| Disease | Drug abuse | 2.58e-04 | 115 | 144 | 5 | C0013146 | |
| Disease | Prescription Drug Abuse | 2.58e-04 | 115 | 144 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 2.58e-04 | 115 | 144 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 2.58e-04 | 115 | 144 | 5 | C0013222 | |
| Disease | Drug Dependence | 2.58e-04 | 115 | 144 | 5 | C1510472 | |
| Disease | Substance Dependence | 2.58e-04 | 115 | 144 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 2.58e-04 | 115 | 144 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 2.58e-04 | 115 | 144 | 5 | C0029231 | |
| Disease | Substance abuse problem | 2.68e-04 | 116 | 144 | 5 | C0740858 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 2.71e-04 | 181 | 144 | 6 | DOID:684 (is_implicated_in) | |
| Disease | Kallmann Syndrome | 2.73e-04 | 26 | 144 | 3 | C0162809 | |
| Disease | Colorectal cancer | 3.06e-04 | 27 | 144 | 3 | cv:C0346629 | |
| Disease | COLORECTAL CANCER | 3.06e-04 | 27 | 144 | 3 | 114500 | |
| Disease | Neoplasm of the large intestine | 3.06e-04 | 27 | 144 | 3 | cv:C0009404 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 3.41e-04 | 28 | 144 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | Hepatoblastoma | 3.50e-04 | 6 | 144 | 2 | C0206624 | |
| Disease | MEDULLOBLASTOMA | 3.50e-04 | 6 | 144 | 2 | 155255 | |
| Disease | Familial benign neonatal epilepsy | 3.50e-04 | 6 | 144 | 2 | C0220669 | |
| Disease | Medulloblastoma | 3.50e-04 | 6 | 144 | 2 | cv:C0025149 | |
| Disease | Intellectual Disability | 3.64e-04 | 447 | 144 | 9 | C3714756 | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 3.79e-04 | 29 | 144 | 3 | C0496920 | |
| Disease | Ovarian Carcinoma | 4.20e-04 | 30 | 144 | 3 | C0029925 | |
| Disease | Amelogenesis imperfecta local hypoplastic form | 4.89e-04 | 7 | 144 | 2 | C0399367 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 5.40e-04 | 206 | 144 | 6 | EFO_0004612, EFO_0020947 | |
| Disease | smoking status measurement | ZNF438 WWP2 REV3L DCC LRPPRC TENM4 SALL1 CELF2 SCN2A CTNNA3 XRN1 ZFHX3 BICRAL DNAH8 ELL | 5.67e-04 | 1160 | 144 | 15 | EFO_0006527 |
| Disease | late-onset Alzheimers disease | 5.99e-04 | 292 | 144 | 7 | EFO_1001870 | |
| Disease | sick sinus syndrome | 6.50e-04 | 8 | 144 | 2 | MONDO_0001823 | |
| Disease | familial sick sinus syndrome | 6.50e-04 | 8 | 144 | 2 | MONDO_0012061 | |
| Disease | ovarian cancer (implicated_via_orthology) | 6.50e-04 | 8 | 144 | 2 | DOID:2394 (implicated_via_orthology) | |
| Disease | obesity (implicated_via_orthology) | 6.75e-04 | 215 | 144 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | CDO1 SYNE1 APC LAMB3 GPR87 DCC ABCA8 CDKL5 CHD5 CTNNB1 DNAH8 | 6.86e-04 | 702 | 144 | 11 | C0009402 |
| Disease | Epilepsy, Cryptogenic | 7.08e-04 | 82 | 144 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 7.08e-04 | 82 | 144 | 4 | C0751111 | |
| Disease | Aura | 7.08e-04 | 82 | 144 | 4 | C0236018 | |
| Disease | Neoplasm Metastasis | 7.08e-04 | 217 | 144 | 6 | C0027627 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 7.61e-04 | 220 | 144 | 6 | EFO_0004529, EFO_0008317 | |
| Disease | HEPATOCELLULAR CARCINOMA | 8.33e-04 | 9 | 144 | 2 | 114550 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 8.33e-04 | 9 | 144 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | Hepatocellular carcinoma | 8.33e-04 | 9 | 144 | 2 | cv:C2239176 | |
| Disease | Glioma | 8.33e-04 | 9 | 144 | 2 | cv:C0017638 | |
| Disease | Malignant tumor of prostate | 8.33e-04 | 9 | 144 | 2 | cv:C0376358 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 8.36e-04 | 224 | 144 | 6 | EFO_0004530, EFO_0008317 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 8.66e-04 | 150 | 144 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | cortical surface area measurement | SCFD2 ZNF438 KRT17 FZD3 SPTBN1 RGPD1 APC CUL9 PARD3B HIF1AN STAT1 CELF2 XRN1 MACF1 ZFHX3 TNKS | 9.05e-04 | 1345 | 144 | 16 | EFO_0010736 |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 9.37e-04 | 229 | 144 | 6 | EFO_0004639, EFO_0008317 | |
| Disease | Non-Small Cell Lung Carcinoma | 1.03e-03 | 156 | 144 | 5 | C0007131 | |
| Disease | unipolar depression, bipolar disorder | 1.03e-03 | 156 | 144 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.04e-03 | 10 | 144 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.04e-03 | 10 | 144 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | Cutaneous Melanoma | 1.06e-03 | 41 | 144 | 3 | C0151779 | |
| Disease | smoking cessation | 1.12e-03 | 325 | 144 | 7 | EFO_0004319 | |
| Disease | Childhood Medulloblastoma | 1.22e-03 | 43 | 144 | 3 | C0278510 | |
| Disease | Melanotic medulloblastoma | 1.22e-03 | 43 | 144 | 3 | C1275668 | |
| Disease | Medullomyoblastoma | 1.22e-03 | 43 | 144 | 3 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 1.22e-03 | 43 | 144 | 3 | C0751291 | |
| Disease | Adult Medulloblastoma | 1.22e-03 | 43 | 144 | 3 | C0278876 | |
| Disease | Squamous cell carcinoma of esophagus | 1.23e-03 | 95 | 144 | 4 | C0279626 | |
| Disease | HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA | 1.26e-03 | 11 | 144 | 2 | 146110 | |
| Disease | Hypogonadotropic hypogonadism 7 with or without anosmia | 1.26e-03 | 11 | 144 | 2 | cv:C0342384 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.27e-03 | 243 | 144 | 6 | EFO_0004612, EFO_0020944 | |
| Disease | left ventricular systolic function measurement | 1.30e-03 | 44 | 144 | 3 | EFO_0008206 | |
| Disease | physical activity measurement | 1.32e-03 | 245 | 144 | 6 | EFO_0008002 | |
| Disease | risk-taking behaviour | KRT17 CUL9 PARD3B REV3L DCC ITIH3 LRPPRC TENM4 ZFHX3 TNKS ANKRD52 | 1.36e-03 | 764 | 144 | 11 | EFO_0008579 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLSNGTANKMNGALD | 16 | O95319 | |
| LNNINALAGMAALNG | 351 | O95319 | |
| ALDGLLQQVANMSAK | 241 | P55199 | |
| MNVLAHGLLQLGQGL | 41 | Q9BY76 | |
| GGNQVSLLNIMMDLK | 976 | Q8TDI0 | |
| QLQEEQLMKLNSGLG | 601 | O14639 | |
| LLATASGNANMVNKL | 701 | P35606 | |
| DIMGTALQNLDGLVQ | 951 | A8K2U0 | |
| MIAKALANESGLNFL | 676 | Q8NB90 | |
| GGLRNNNEKDMALTA | 1131 | P01024 | |
| QLGALLAGMHTLLQQ | 81 | Q9GZQ3 | |
| QEGVSNALLKMAELG | 66 | Q9NWX5 | |
| KLQQLMAAALAELEG | 936 | Q96M86 | |
| ILQLLLMSGANVNAK | 56 | Q8NB46 | |
| LGNRKALAQLFVNLM | 316 | Q9P1Z9 | |
| IRAGALTGKENNMLQ | 16 | Q5HYR2 | |
| PDGLMKLNGSALNNE | 316 | Q76L83 | |
| LLLAKAVQNVGNMDT | 501 | O43374 | |
| LLLAKAVQNVGNMDT | 501 | C9J798 | |
| EACQLGLLQSMGKQG | 966 | A6NNM3 | |
| EACQLGLLQSMGKQG | 966 | A6NJZ7 | |
| MNDQLIAVNGESLLG | 546 | Q8TEW8 | |
| AGGLQKMVALLNKTN | 276 | P35222 | |
| LALGMDERKQQLSNG | 81 | P43146 | |
| SLEGLMKQLNAITGS | 1431 | P43146 | |
| IGMTKADLINNLGTI | 91 | P08238 | |
| ASDGLLAGNEKLTMQ | 71 | P08727 | |
| LQGLSDLKVMDGSQV | 626 | Q15746 | |
| KAVAGMLVLSIQGNL | 221 | Q6P499 | |
| MILGQIFLNGNQAKE | 586 | Q9HCI5 | |
| QLQGLSASAGLLEQM | 1846 | Q16787 | |
| MGKEVGNLLLENSQL | 416 | Q9UPT6 | |
| QLTSNLLLIGMEGNV | 181 | Q9NWT6 | |
| GTQALLELKAGLENM | 476 | Q9NPH3 | |
| LELKAGLENMASRGN | 481 | Q9NPH3 | |
| IGMTKADLINNLGTI | 91 | Q58FF8 | |
| QGLTANSLLDRGMQL | 1561 | Q2LD37 | |
| DGGLLTGNEKITMQN | 96 | P13646 | |
| GLISQLEMDQQAGKL | 621 | O95202 | |
| LGKLRNDGSLMFQQV | 41 | Q16772 | |
| LQDSLGGNAKTIMVA | 326 | O14782 | |
| NLRGNMVANLGELAK | 251 | Q53EV4 | |
| GNVAQDLGLKMTDLL | 46 | Q9Y5F6 | |
| ASKGLLNGIRDMLAN | 46 | Q96JB1 | |
| MSQEANLLLAKAGDG | 456 | O75037 | |
| QQLSNDGMLVILAAG | 391 | Q49A26 | |
| AIKALLNGEGAINMV | 691 | Q8TDM6 | |
| GIQSLLNGGRMKLTQ | 241 | Q6AI08 | |
| VQKMLNGLEDSIGLS | 1161 | P42704 | |
| NVGNVILLNMDGKEL | 221 | Q92466 | |
| ATGIKNGLALHLMAQ | 361 | Q05925 | |
| MGFNLTLAKLPNNEL | 1 | Q9BY21 | |
| KIDNLLQEMLLGGAS | 316 | Q14541 | |
| LLGASNADQLMENIG | 321 | Q13303 | |
| MQKGLLDQDTGLVLL | 1566 | Q9UPN3 | |
| GTLVIIFNLKLMDNG | 196 | Q9Y6X9 | |
| SMLGSLQSDLNKLGV | 336 | P49023 | |
| LALQGNGLMVLQVDL | 496 | Q14392 | |
| KAEIQNLGGELIMSA | 786 | Q9UI47 | |
| IMLSLQNILNGLGAA | 156 | Q86XA9 | |
| AGGEKATMQNLNDRL | 81 | Q04695 | |
| VMLGNKAQTVLNGNL | 1171 | P54132 | |
| MTINNLDGSQIILKG | 226 | Q6AI39 | |
| QDLGLEFLNLINMAK | 621 | Q6ZP82 | |
| SQLTLSGLNGAQMEK | 396 | P51587 | |
| QKLLDQGALLMGKTN | 106 | Q9H0R6 | |
| QGALLMGKTNLDEFA | 111 | Q9H0R6 | |
| MGTLQQALQGKDALS | 746 | H7BZ55 | |
| NLVDQGNGKFNLMIL | 61 | Q16878 | |
| STKMQILEGLGLNLQ | 86 | P05154 | |
| GMSAEQAQGLLEKIA | 146 | Q9Y2Q3 | |
| RGAALKLGQMLSIQD | 271 | Q8NI60 | |
| GGMLVQKLNTNDLQS | 176 | A0PJE2 | |
| GAALKVGQMLSIQDN | 151 | Q96D53 | |
| LLAMNKIEGDNISGV | 346 | Q9NPG1 | |
| AAFLAMLGLQGNKQV | 221 | A6NK06 | |
| MLGLQGNKQVLDLEA | 226 | A6NK06 | |
| NARLNGGKVQLNLMD | 181 | Q13751 | |
| QLQRMEALISKAQGG | 626 | Q13753 | |
| QQAGLAALKMLAVAS | 791 | Q8IWT3 | |
| ALVQGLMGAAVTLKN | 296 | O75208 | |
| LMGAAVTLKNLTGLN | 301 | O75208 | |
| DINLSVNLKGEGMSQ | 296 | P16930 | |
| IGMTKADLINNLGTI | 96 | P07900 | |
| IGMTKADLINNLGTI | 36 | Q58FG1 | |
| GMSLKQQLLGERNLL | 836 | A6NE01 | |
| VQELELKLSGQNAMG | 356 | O75052 | |
| LKLSGQNAMGSQDSL | 361 | O75052 | |
| MSKLNQNLNDVLVGL | 256 | O00499 | |
| IALMDTDGSGKLNLQ | 701 | P20807 | |
| IGQGMAARANSLQLL | 631 | O76039 | |
| KMINAGLAEQLQASL | 871 | Q9NSC2 | |
| IGMTKADLINNLGTI | 96 | Q14568 | |
| LGNKNTVLLGLGFQM | 316 | Q5SR56 | |
| QLALKPGLIGNANMV | 216 | O43395 | |
| YLIGNLNSENNKMIG | 566 | Q7L1W4 | |
| GSLLLKMGQHGNNVQ | 286 | P0DJD0 | |
| AGKVHNFMLGLNLNT | 486 | P47712 | |
| NSLLGRKGSLEKMNN | 431 | Q6ZN16 | |
| QDGGLLLNNPSALAM | 626 | Q9NP80 | |
| HMLLQGLTNKLQVGD | 1906 | O75691 | |
| EMQQLSGGQKSLVAL | 1111 | Q9UQE7 | |
| VDQLNMLGEKLLGPN | 516 | P42224 | |
| NNLNGILADEMGLGK | 741 | P51531 | |
| LNMAIGKGEQALRSS | 2681 | Q8NF91 | |
| SAEQMIGDIINLGLK | 721 | O15061 | |
| DLKNQMVLLQGGEAL | 86 | Q9BRQ8 | |
| EACQLGLLQSMGKQG | 966 | Q9UFD9 | |
| NINDGLLRGISMLNK | 361 | Q06033 | |
| AIMLLNTDLHGQNIG | 686 | Q8NDX1 | |
| LGLVMLGSKNAQAIE | 516 | Q99460 | |
| NQLMNGTLGDSELEK | 296 | O43147 | |
| NNLNGILADEMGLGK | 771 | P51532 | |
| LTQVGSILGNLKDMA | 156 | O00161 | |
| SILGNLKDMALNIGN | 161 | O00161 | |
| GKNQNGTHALSILLM | 86 | Q8N7X8 | |
| LQQMQDGELTQGSLL | 396 | Q03519 | |
| GLKVSLQRNMGNGLL | 771 | O75626 | |
| NLKALMNHCGLLQLG | 396 | Q8WU76 | |
| TGNMGLAMKLQNLQL | 526 | P22307 | |
| SLLAALLGQMQLQKG | 521 | Q96J65 | |
| VGLEQLGFNALLQLM | 256 | O75783 | |
| VAQDLSQQLDGLLGM | 386 | Q86VW0 | |
| TQDLGNDLAGVMALQ | 981 | Q01082 | |
| NDLAGVMALQRKLTG | 986 | Q01082 | |
| GVDGKLSSINNMGLN | 521 | P35712 | |
| MKNIQDVLAQNLSGG | 606 | O94911 | |
| MNELGGLQAIAELLQ | 466 | P25054 | |
| QGGSLPASMQLQKLN | 106 | Q99967 | |
| NMGQSVDISGLQLAL | 211 | Q9UKZ1 | |
| LLAVLEKMISQGNNN | 171 | Q9H9A5 | |
| LLIGKDTSLLGNGQM | 981 | Q9Y2G3 | |
| LNRSIQKLGELNIGM | 476 | O94967 | |
| MIAGLGKAAELVTQN | 301 | Q96I15 | |
| GMLGTEDLLKFIQLN | 481 | Q9P2K2 | |
| VNLSNVLKNNGGKME | 101 | O00308 | |
| GNLQMLEQLDLIGKT | 2526 | O60673 | |
| GNGLAAGKMNISIDL | 11 | Q6IEE8 | |
| LKAPVLNLNQGMDNG | 221 | O95210 | |
| LANLGAKCLQMLDSG | 16 | Q2QD12 | |
| LQQGEEAMQKALGIL | 76 | P49675 | |
| EAMQKALGILSNQEG | 81 | P49675 | |
| GAKMNALDTLGQTAL | 581 | O95271 | |
| GLDMNISQFLKSLGL | 1026 | O95271 | |
| GLQLFMGNLRNKCLQ | 266 | Q99250 | |
| KAALFALQQLGSLGM | 1496 | Q8IZH2 | |
| ETAGMLKTINLQNEG | 2036 | Q6N022 | |
| ALIGLQLFMGNLRNK | 266 | Q9UQD0 | |
| KLNGGGQIMLNSLHK | 151 | O15178 | |
| KIAEGVNSLLQMAGL | 326 | P35250 | |
| LQVGLQASAQMGLLR | 341 | Q86VD9 | |
| VQMLGSLGGQINKNL | 856 | P78527 | |
| QQMDLLGKLFENDTG | 261 | Q9H0C1 | |
| VLNLIINNGNSSGMK | 141 | Q9BY31 | |
| MLEALKNSSGANLQG | 136 | O43149 | |
| LSAEQLMGSDGNKLL | 411 | Q96JM2 | |
| AMKLANGAIELDTGN | 16 | Q9Y2B5 | |
| NMIANGKLAEGVQLL | 1056 | Q9BZH6 | |
| KLTNKLNGGGQIMLN | 146 | O60806 | |
| LQSQMLGGLGQDVLL | 456 | Q7Z4V0 | |
| LLQGLNMLQSGLHKQ | 786 | Q9Y4A5 | |
| NMQVLKSHGLFGLNE | 136 | Q96H79 | |
| KANEVLGLAAQQQGM | 3086 | Q15911 | |
| SNLQKQLEMLSGDGV | 181 | Q14CN4 | |
| GADQTLLQKLQMQIG | 476 | Q12965 |